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Abstract 
 
This thesis describes attempts to develop new technically clean radical cyclisation 
technologies. The work focuses on novel radical oxidation processes, whereby 
selective hydrogen-atom abstraction forms carbon-centred radicals able to 
undergo intermolecular radical additions, or cyclisation to form 5- 6-membered 
rings.  
 
A new and unreported cyclisation pathway has been identified, albeit a low 
yielding pathway. This novel N-halosuccinimide cyclisation technology 
constructs cyclic architectures of med-chem importance and crucially without the 
requirement for tin or other toxic metals. 
 
Particularly noteworthy was the use of N-iodosuccinimide to promote cyclisation 
of dihydro-isoindol-1-one derivatives (Figure 1a).  
 
            
 
Figure 1a Resulting products of NIS reaction, successful cyclisation   
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Preface 
 
“So what do you do?” is a question everyone is invariably asked at one point in 
their life, possibly by an estranged relative or an acquaintance of an acquaintance 
at some party. Using a party for an illustrative example, when I’m asked this exact 
question, first I convince them “I’m a chemist” does not mean I work at a local 
pharmacy and is in fact referring to being a student of the science that is 
Chemistry. The conversation swiftly moves on to “What sort of Chemist?” (Or at 
least after the “I didn’t like chemistry at school” diatribe). My response “an 
Organic Chemist” has usually mixed responses, either empathic nods or “do you 
work with plants and stuff?” it really depends on the party. The challenge at this 
point is now to communicate exactly what it is that you are interested in.  
 
I’m primarily interested in the use of free radicals in organic synthesis. Free 
radicals the term is well known to most people, most of the PR has already been 
done by companies wishing to sell the odd fruit juice or skin care product. But the 
actual understanding of what exactly free radicals are and their uses in synthetic 
chemistry are by and large not known by most party revellers. 
 
So “what are free radicals?” a person might ask during such a party out of 
politeness or a pathological fear of silences. “A radical is an atomic or molecular 
species having an unpaired, or odd, electron; this makes radicals highly 
chemically reactive towards other substances and themselves”. 
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“So what are you using the radicals for?” the fictional and now slightly peakish 
party goer asks. “Well I’m interested in using radicals for developing new 
synthetically useful addition and cyclisation reactions”.  
 
The reveller after an unfortunate episode beside an imitation tropical plant 
regained composure and retorted with a hint of contempt “what is the point?” 
before returning to heave over the plastic plant once more.  
 
It is an adept question, the best way to answer such a question is to first explain 
that radical reactions can offer a number of advantages over ionic transformations; 
the first being that although carbon centred radicals are extremely reactive, radical 
addition reactions can proceed under mild, neutral conditions, and the reactivity of 
radicals does not compromise a high level of chemio-, regio-, and 
stereoselectivity. Even conformational restrictions often increase the rates and 
increase the stereoselectivity of radical cyclisations. Another advantage of using 
radicals is that they are not cluttered with counterions or aggregation spheres, 
because they are neutral and because their reactions have early transition states, 
Radical intermediates are ideally suited for the synthesis of crowded bonds. 
Radical reactions  do not  need to be dry, and  the  protection  of  alcohols, 
amines, and  related functional  groups  is  often unnecessary.  The same is rarely 
true for reactions involving carbanions or carbocations due to their respective 
basicity, nucleophilicity and electrophilicity. 
 
With these advantages it is perhaps surprising that radicals have made limited 
inroads in being used in industry, which is mainly due to the dependency of 
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radical chemistry on trialkyl-tin hydrides (e.g. Bu3SnH). But there lies the scope a 
lot of untapped potential for organic chemists. With every year comes a new 
radical methodology for constructing and functionalising molecules. The remit of 
this thesis is within this race for new, cleaner and more efficient technologies. 
 
David S. J. Creighton  
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Chapter One: Introduction 
         
1.1 The “Roots” of Radicals 
 
The word radical comes from the later Latin Radicalis “of roots” and Latin Radix 
meaning “root”. I intend to use this chapter to get to the roots of where radical 
chemistry began and show how it has anchored itself in organic synthesis and its 
future. 
 
I have chosen to begin the story of radicals unconventionally with the 
assassination of an Emperor.
1
 In 1881 the self-proclaimed “Narodnaya Volya” (or 
People’s Will) were a radical revolutionary group, who felt the drastic need to end 
Tsar Alexander II’s life, who died of his injuries after they detonated a bomb 
underneath his carriage. This audacious regicide had a swift and formulaic 
response, triggering retrograde political reforms throughout the Russian Empire 
by Alexander II’s less enlightened successors.2  
 
The relevance of this geo-political turbulence to the genesis of radical chemistry 
was the emigration of a young Moses Gomberg along with his family to the 
United States of America in 1884 to avoid the presumably unjust imprisonment. 
Gomberg’s story from a refugee to great of organic chemistry is an inspiring one,3 
where he overcame many obstacles to become a successful scientist, but I shall 
refrain from telling this story as it is the story of radicals and Gomberg’s part to 
play is what I want to impart to the reader. 
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The event leading to Gomberg’s discovery of stable and persistent organic free 
radicals begins with Moses paying a visit to Victor Meyer’s laboratory with the 
sole intention of synthesising a compound which other chemists had failed to 
make. That compound was tetraphenylmethane (Ph4C), which had already 
claimed many a scalp including Gomberg’s host Meyer. Armed with some 
youthful bravado, Gomberg demonstrated his technical skill and chemical 
intuition in the lab and designed a completely new synthesis and after a few days 
of intensive lab work he isolated a small amount of the desired compound. His 
success spurred him on to attempt to isolate the next fully phenylated hydrocarbon 
hexaphenylethane (Ph3C-CPh3), not a man to take it easy.
4
  
 
The synthesis of this compound involved the treatment of triphenylmethyl 
chloride (or trityl chloride, Ph3CCl) with metallic sodium. The reaction however 
did not proceed. Gomberg moved to rectify this by deploying silver instead of 
sodium. This time the reaction did proceed, and he isolated a white crystalline 
substance. On analyzing the compound using elemental analysis and to his 
surprise he concluded the compound contained oxygen.  
 
Using the process of elimination Gomberg determined that the source of the 
oxygen was atmospheric, and he repeated the experiment in the absence of air. 
This time the crystals did not form and instead he isolated a different compound 
that did not contain oxygen but was not hexaphenylethane. Gomberg had 
rationalised that the oxygenated compound was in fact triphenylmethyl peroxide 
(Ph3C-O-OPh3). The second compound however demonstrated interesting 
reactivity comparable to highly unsaturated hydrocarbons. Gomberg concluded 
13 
 
although reluctantly that to explain this reactivity he had synthesised a free 
radical, triphenylmethyl Ph3C• (Figure 1b).  
 
Gomberg’s work was not immediately heralded by his peers and caused great 
debate as to whether a radical even need be invoked.
5
 
 
 
Figure 1b Trityl chloride reacting with silver forming the triphenyl methyl radical 
 
Radicals unfortunately continued to be regarded as esoteric constructs with no 
relation to organic chemistry. However finally in 1937, three papers appeared that 
did much to cement the role of radicals in organic chemistry. The first paper was a 
review by Hey and Waters.
6
 The second was the work by Kharasch, Engelmann 
and Mayo
7
 on the unusual mode of addition of hydrogen bromide to alkenes, 
which was demonstrated to involve a radical chain reaction. The third was the 
kinetic analysis of vinyl polymerisation which was also shown to be a radical 
chain process by Flory,
8
 who proposed the concept of chain transfer. These three 
publications made radicals acceptable to the mainstream scientific community and 
marked a watershed in the development of radical chemistry.  
 
Radical chemistry accelerated from 1939 onwards, though unfortunately this 
progress was catalysed by the all too familiar feature of 20
th
 century, mechanised 
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warfare. Chemists were called upon by the Allied and Axis war efforts in WWII 
to develop and supply synthetic rubbers. This became a greater priority for Allied 
nations due to the expansion of the Japanese Empire into Southeast Asia in 1942 
which consolidated Axis control over global natural rubber supplies. Natural 
rubber was a strategically vital resource for the United States which lagged behind 
in synthetic rubber production. Rubber was needed for an array of different 
components in war machines. As a result polymer chemistry became vitally 
important; as vinyl polymerisations were radical processes this meant radical 
chemistry became a priority area of funding and research.  
 
Academic interest in radical chemistry continued after the war and began to 
concentrate developing new classes of radical additions for synthetic purposes.
9
  
 
Simple examples of radical cyclisations emerged in the 1960’s, 10 and they are 
now established as an important method of forming rings, particularly 5- and 6-
membered rings. A number of reviews in the area have been reported, discussing 
radical cyclisation methodologies based on reagents including tributyltin hydride 
and samarium diiodide
11
. This forms a large percentage of radical cyclisations 
used in organic synthesis, with elaborate radical cascade sequences forming 
polycyclic natural products.
12
 
 
1.2 Radical Cyclisations in Literature 
 
There are numerous beautiful examples of these cyclisations in literature; a 
personal favourite of mine is Curran’s classic total synthesis of hirsutene13 in 
15 
 
1985, a masterful showcase of the tributyltin hydride radical methodology (Figure 
2). 
 
Figure 2 A radical cyclisation cascade in the total synthesis of (±)-hirsutene 
(Curran and Chen, 1985) 
 
Hirsutene is a tricyclopentanoid natural product, and possesses 
antibiotic/antitumor activity
14
. The primary iodide is transformed directly into 
hirsutene. Two carbon-carbon bonds are formed, installing two continuous 
stereogenic centers (one quaternary) and furnishing two carbocyclic rings.  This 
reaction is very fast, high yielding and stereoselective. In this case a cis-ring 
junction is formed, this is because 5-membered rings are relatively small; the 
transition state leading to the cis-ring is relatively free from strain therefore 
Radical 
cyclisation 
cascade 
 
n-Bu3SnH 
cat. AIBN 
Benzene 80 
o
C 
80 % yield  
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allowing the SOMO to overlap efficiently with the π* LUMO, this overlap is not 
possible in the transition state leading to a trans junction. 
 
This example is one of many that dispelled the perception that free radicals were 
too reactive to be of any use in the efficient synthesis of small molecules and 
illustrates what tandem radical cyclisations are especially good for constructing 
highly hindered carbon-carbon bonds and forming quaternary centers.  
 
Synthetic chemists have a particular interest in constructing a class of compound 
known as alkaloids. The construction of carbon-carbon bonds adjacent to nitrogen 
plays an important role in alkaloid chemistry. Alkaloids are of great interest due to 
their biological activity, two examples being indicine N-oxide (Figure 3) which 
has anti-cancer properties (a pyrrolizidine alkaloid)
15
 and castanospermine (Figure 
4) a potent glycosidase inhibitor and potential AIDS drug (an indolizidine 
alkaloid).
16
 
                                                        
Figure 3 Structure of indicine N-oxide           
 
       
Figure 4 Structure of castanospermine                                                        
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These molecular architectures can be constructed using radical cyclisations by 
generating α-amino and α -acylamino radicals using tributyltin hydride.  
 
An early pioneer of this chemistry was David Hart
17
, who developed in the 1980’s 
selective routes to these alkaloids using tributlytin hydride, the success of which is 
demonstrated below (Figure 5).
18
 
 
 
 
Figure 5 Cyclisation of a thiophenoxylactam with Bu3SnH (Hart, 1981)  
 
The treatment of a precursor thiophenoxylactam with Bu3SnH gave an exo-
cyclisation product and an endo-cyclisation product. The endo-product is an 
intermediate in the synthesis of the indolizidine alkaloid gephyrotoxinm (Figure 
6). No reduction products were obtained and both cyclisations proceeded with 
high stereoselectivity 
 
Gephyrotoxin is a naturally occurring natural product that comes from the tropical 
Harlequin poison dart frog (Colombia). This alkaloid skin secretion has shown 
interesting neurological activity
19
.
 
Another route to these alkaloids has been 
developed by Parsons
20
 using a tandem radical cascade (Figure 7). 
 
Exo 51% yield Endo 31% yield 
n-Bu3SnH 
cat. AIBN 
Benzene 80 
o
C 
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Figure 6 Structure of the natural product gephyrotoxin 
 
 
Figure 7 Tandem radical cyclisation leading to indolizidinones and 
pyrrolizidinones (Parsons, 1998) 
 
This tandem cyclisation approach provides a quick and mild entry to both 
indolizidine and pyrrolizidine ring systems. The selectivity and high yield of this 
reaction towards to indolizidine is particularly impressive (Route B, Figure 7).  A 
good example of a high yielding indolizidine reaction is shown below (Figure 8), 
with a single diastereoisomer of a tricyclic product being isolated in 61% yield.  
Bu3SnH 
AIBN 
19 
 
 
Figure 8 Regioselective tandem radical cyclisation using Ph3SnH (a 5-endo-6-
endo cyclisation sequence) 
  
The reason behind this exclusive 6-endo-cyclisation to the tri-substitued double 
bond is due to steric obstruction. The attraction of this chemistry is not only its 
high yields or regioselectivity but it can be augmented to give different cyclisation 
products this time through a 5-endo-5-exo-cyclisation pathway (Route A, Figure 
7). In the next example the pyrrolizidinone product is isolated in a comfortable 
55% yield (Figure 9). 
 
            
Figure 9 Regioselective tandem radical cyclisation using Ph3SnH (a 5-endo-5-exo 
cyclisation sequence) 
 
The regioslectivity can be effectively modulated by the ester substituent which is 
stabilising the radical in the transition state, seducing it into a 5-exo cyclisation.  
As elegant as these examples are, the general deployment of these reagents in the 
synthesis of pharmaceuticals in industry is not likely or desirable due to their 
Ph3SnH 
cat. AIBN 
Benzene, heat 
20 
 
severe toxicity. This presents a challenge and opportunity for interested synthetic 
chemists to meet this problem. The search for alternative stable, non-metal, free 
radical species capable of abstracting hydrogen from these compounds is being 
pursued. One class of compounds that has potential to fill this role are nitroxides. 
 
1.3 Nitroxides And Their Uses In Organic Synthesis 
 
1.3.1 Nitroxides and their stability 
 
Nitroxides or nitroxyl radicals are N,N-disubstituted NO radicals with a 
delocalised unpaired electron shared between the nitrogen and the oxygen atoms 
(Figure 10).  
 
 
Figure 10 Stability of N-oxy radical owes much to delocalisation of the unpaired 
electron over N-O bond 
 
Nitroxyl radicals owe their stability to several factors; they have sufficient 
conjugation with the nitrogen’s lone pair. Various conformational advantages aid 
this conjugation, there is no twisting of the N-O bond and no substiuents are 
present of the oxygen atom. The stability of nitroxides is influenced by the 
electron density on the nitrogen, for example aminoxyl radicals (Figure 11) are 
more stable than imidoxyl radicals (Figure 12) as the alkyl groups donate electron 
21 
 
density towards the nitrogen, while the acyl groups will decrease the spin density 
on the nitrogen as they are electron withdrawing groups
21
. 
 
                                                                           
Figure 11 Aminoxyl radical                           Figure 12 Imidoxyl radical 
 
1.3.2 Synthetic Applications of TEMPO (2,2,6,6-Tetramethylpiperidin-1-
yloxyl) 
 
Nitroxides first featured in synthetic procedures with an inorganic nitroxide called 
Fremy’s salt (Figure 13), which has been used as an oxidant in organic synthesis 
for many years
22
, useful for oxidising phenols to quinones (Figure 14)
23
. 
 
                  
Figure 13 Fremy’s salt             
 
 
Figure 14 Phenol oxidation to a quinone  
(KSO3)2NO, KH2PO4 
 
H2O 
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But by far the most synthetically successful organic nitroxide is TEMPO (or 
2,2,6,6-tetramethylpiperidine-1-oxyl) (Figure 15), which is easily prepared, stable 
and persistent
24
. TEMPO was first reported by the Russian duo Lebedev and 
Kazarnovsky back in 1959
25
.       
                                                        
Figure 15 Structures of TEMPOH and TEMPO radical 
 
Since TEMPO’s debut it has found extensive applications in synthetic chemistry 
documented in numerous reviews
26
, primarily as a catalyst for oxidation reactions, 
for instance in the oxidation of alcohols. One of the most widely studied TEMPO 
oxidations are copper-TEMPO catalysis reactions with oxygen, an early example 
by Semmelhack et al
27
, which showed that benzylic or allylic alcohols could be 
oxidised into aldehydes (Figure 16). 
 
Figure 16 Cu(I)-TEMPO catalysis (Semmelhack, 1984)
27 
 
Sheldon et al. have studied these systems in great detail and have published many 
papers and reviews
28
 on the exact nature of the reaction mechanism. Sheldon et al. 
CuCl (10 mol%) 
TEMPO (10 mol%) 
 
 
DMF, RT, O2 
 
23 
 
have also developed new and more selective Cu-TEMPO alcohol oxidations
29
. 
For example the reaction below has a remarkable selectivity for primary alcohols 
(Figure 17). 
 
Figure 17 Selective copper-TEMPO oxidation (Sheldon, 2003)
 29
 
 
Sheldon has also developed useful ruthenium-TEMPO alcohol oxidation 
reactions
30
 (Figure 18), which can oxidise a broad scope of alcohols and is a 
useful alternative to traditional metal based oxidation methods. 
 
Figure 18 Ruthenium-TEMPO catalysis with O2 (Sheldon, 2001)
 30
 
 
TEMPO however is inefficient for oxidising hindered secondary alcohols; 
however another nitroxide, the AZADO radical (Figure 19), can be used to 
oxidise sterically hindered alcohols with greater efficiency than TEMPO.
31
 
 
 
RuCl2 (PPh3)3  
TEMPO (3 x mol%) 
 
PhCl, 100 
o
C, O2 
 
5 mol% TEMPO; 5 mol% t-BuOK 
CH3CN/H2O (2:1) 
Air, 25 
o
C 
 
5 mol% CuBr2, 5mol% 
 
24 
 
 
Figure 19 Introduction of fluorine at C5 position (Iwabuchi, 2011)
 31
 
 
Iwabuchi et al.
32
 used a fluorinated AZADO radical (Figure 19) for greater 
efficiency still and can manage a diverse range of hindered alcohols (Figure 20) 
. 
 
Figure 20 Oxidation of hindered secondary alcohols using 5-F-AZADO radical 
(Iwabuchi, 2011)
32 
 
As useful and benign as these TEMPO reactions are, they are of no assistance for 
radical cyclisations. There are a few examples of TEMPO H-abstraction
33
, but the 
simple truth of it is that TEMPO is not up to the task. This is due to its stability, 
which is related to the O-H bond dissociation energy (BDE) in the parent 
hydroxylamine. The alkyl groups in TEMPO donate electron density to the 
nitrogen which increases conjugation and decreasing the BDE of the O-H and 
making it limited in its scope with regards to H-abstraction. H-abstraction by 
TEMPO will be highly endothermic with most substrates. 
 
5-F-AZADO (1 mol%), 
NaNO2 (10 mol%), AcOH (1M) 
 
Air (balloon), RT 
 
5-F-AZADO  
 
AZADO  
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However, TEMPO is finding new oxidative roles, with a lot of interest in C-H 
activation, the aspiration of being able to stimulate reactions at C-H bonds rather 
than having to pre-functionalise a compound is very attractive and a rapidly 
advancing field of synthetic chemistry. For example Baran et al
34
 has found a way 
to install double bonds into unactivated carbon chains. Trifluoroacetic acid 
generates a radical on the aryl ring, which abstracts a hydrogen from the nearby 
carbon to generate a second radical, which is then oxidised to a cation, followed 
by deprotonation to make an alkene. In this way TEMPO is a radical oxidant, and 
does not abstract a hydrogen atom but it is a good example of the use of TEMPO 
expanding into new and exciting areas (Figure 21). 
 
  
Figure 21 Selective introduction of C=C bonds (Baran, 2012)
34 
 
 
 
 
 
TEMPO (1 equiv) 
CH3NO2 
 
 
TFA (3 equiv), 60 
o
C, 1.5 
hr or TfOH (2 equiv), RT, 
3 hr 
 
26 
 
1.3.3 Synthetic applications of PINO (phthalimide N-oxyl) 
 
 
Figure 22 Structure of NHPI and PINO radical 
 
There is an alternative persistent nitroxide
35
 available in the form of phthalimide 
N-oxyl radical or PINO (Figure 22). This can be generated from NHPI with 
various oxidants and is far more reactive than TEMPO. The greater reactivity of 
PINO is due to its relative instability, the acyl groups next to the nitrogen are 
electron with drawing in nature and therefore decrease electron density on the 
nitrogen and increasing the BDE of the O-H bond in NHPI which translates to 
greater reactivity of the nitroxyl radical. 
 
The O-H bond energy in NHPI is very close to the O-H bond in an 
alkylhydroperoxide, therefore H-abstractions from most organic substrates will be 
mildly exothermic. 
 
An early example of use of NHPI in synthesis is Grochowski’s36 coupling reaction 
between ethers and DEAD (diethyl azodicarboxylate) published in 1977 (Figure 
23). 
Catalyst 
 
27 
 
 
Figure 23 NHPI-mediated coupling between ethers and DEAD (Grochowski, 
1977)
36 
One reaction of particular interest is a nitroxide-catalysed methodology developed 
by Ishii et al.
37
 Which is often referred to as the “Ishii system”. This system has 
been shown to oxidise C-H bonds using O2: potentially providing a green 
alternative method for the oxidation of bulk chemicals. Ishii has accomplished the 
remarkable feat of oxidising alkanes
38
 (Figure 24), though the conversions fot 
simple alkanes are low. 
 
Figure 24 Alkane C(sp
3
)-H oxidation catalysed by NHPI (Ishii, 1995)
 38
 
 
The methodology can boast the accolade of the first example of catalytic aerobic 
oxidation of toluene at room temperature
39
 (Figure 25). 
 
Figure 25 Aerobic oxidation of toluene at room temperature (Ishii, 1997)
 39
 
Co(OAc)2 (0.5 mol%) 
NHPI (10 mol%) 
Co(acac)2 (0.5 mol%) 
NHPI (10 mol%) 
O2 (1 atm), 100 
o
C 
          PhCN 
O2 (1 atm), 25 
o
C 
          AcOH 
NHPI cat. 
28 
 
But by far the most intriguing accomplishment of Ishii, is the system’s ability to 
perform intermolecular radical additions
40
, Radicals derived from dioxolanes can 
add to electron-poor alkenes to form the corresponding β-hydroxy derivatives 
(Figure 26).  
 
Figure 26 Ishii system’s application for C-C bond formation 
 
This carbon-carbon forming reaction is, triggered by H-abstraction from the 
dioxolane by PINO. If PINO can remove hydrogen from dioxolane could it 
possibly generate an alpha-acylamino radical, or related radicals that could 
undergo an intramolecular radical cyclisation? 
 
1.4 Research Objective 
 
Free radical oxidations play an important role in natural processes including 
ageing
41
 and have a wide use in synthesis. However these transformations are 
often described as “difficult reactions,” typically giving numerous products in low 
yields, with poor selectivity. Many metal-based conventional catalysts are toxic 
and difficult to separate. Recently organic oxidation catalysts started attracting 
attention due to the potential for tunable selectivity and cleaner
42
, more 
environmentally friendly chemistry. This is however an emerging area of 
Co(OAc)2 (0.5 mol%) 
NHPI (10 mol%) 
O2 (1 atm), 25 
o
C 
29 
 
synthetic chemistry and only a few catalysts have been successful. One of these 
successful catalysts is a class of organic radicals called nitroxides. 
 
This thesis is concerned with investigating the viability of nitroxides as a potential 
alternative in intramolecular carbon-carbon bond forming radical reactions. The 
Ishii system, which was detailed in the previous section, will be the ideal nitroxide 
based methodology to exploit for this investigation.  
 
The global aim being developing environmentally benign chemistry, operating at 
an ambient temperatures. It is envisaged that this chemistry can be exploited in 
order to perform oxidative intramolecular radical cyclisations, as illustrated in 
Figure 27. It is hoped that such a technology could offer a viable alternative to 
trialkyltin reagents. Alternative nitroxide systems and benign alternative radical 
initiators will also be explored (e.g. N-halosuccinimides and alkylboranes) 
 
Figure 27 Potential med-chem relevant, oxidative intramolecular radical 
cyclisation, constructing pyrrolizidinone alkaloid structures. 
 
Lactams bearing unsaturated  chains will be synthesised and then subjected to 
different nitroxides and other stable free radicals and their reactivity explored. The 
following chapters documents the pursuit of such a cyclisation technology 
 
H-abstraction 
5-exo-trig 
cyclistion O2 
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Chapter Two:  Results and Discussion 
 
2.1 Optimisation of Ishii’s Nitroxide-catalysed Radical Addition Reaction 
 
As mentioned in the Introduction the project aims to exploit Ishii’s nitroxide-
catalysed radical addition
40
 chemistry to perform some oxidative intramolecular 
reactions to construct useful alkaloids.  Before exploring new radical cyclisation 
methodology, Ishii’s work was replicated. The reaction of interest is shown in 
Figure 28. 
    
 
Figure 28 Ishii’s nitroxide-catalysed  radical-addition, between methyl dioxolane 
and methyl acrylate 
 
 The mechanism of the reaction is shown in Figure 29, and starts by hydrogen 
abstraction from NHPI, using 1g giving PINO which then abstracts a hydrogen 
atom from dioxolane 1a to form a dioxolane radical. The (nucleophilic) radical 
adds regioselectivly to the acrylate C=C bond, yielding a radical adduct. In the 
presence of oxygen, the resulting radical is rapidly trapped by O2 to give a 
hydroperoxyl radical which then forms hydroperoxide. It is well known that 
hydroperoxides are subject to redox decomposition by cobalt(II) ions to form an 
1a 1b 1c 
 NHPI (10 mol%) 
 Co(OAc)2 (0.5 mol%) 
O2 (1 atm)  
     25 
o
C 
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alkoxyl radical which is eventually converted into the alcohol product 1c, via 
hydrogen abstraction from either NHPI or dioxolane 1a. 
  
 
Figure 29 Plausible mechanism for the PINO catalysed radical addition, a 
Co(III)-dioxygen complex derived from the Co(II) species and O2 assists the 
formation of the PINO radical from NHPI. 
 
The Ishii conditions used catalytic amounts of NHPI and Co(OAc)2 and molecular 
oxygen deployed from a balloon. The first time this reaction was investigated a 
balloon was not used to deliver the oxygen (air), but the reaction flask was left 
1a 1b 
1c 1d 
1e 
1g 
Reduction 
O2 
PINO 
O2 
NHPI 
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open to atmospheric oxygen. The reaction did proceed albeit in low yield which 
was encouraging. But it was soon found that there were some unwritten intricacies 
to this reaction (next page).  
 
Ishii reported the desired product 1c being formed in 81% in 3 hours. On 
performing the reaction following the exact procedure as outlined in Ishii’s paper, 
an average yield of only 33% was obtained (after column chromatography) 
 
It was noticed that the reaction did not proceed as quickly as stated by Ishii; when 
worked up after 3 hours the typical yield of 1c was 27-29%. Even leaving reaction 
mixture for much longer in later attempts did not increase the yield. However 
although longer reaction times did not improve the yield of 1c, the yield of an 
unreported side product did increase.  
 
It is important to get the delivery of oxygen correct in order to achieve reasonable 
yield of 1c. Sticking in a balloon (affixed to a needle) and letting the reaction run 
its course did not lead to high yields of 1c. From trial and error, it was found that 
placing the needle just barely above the surface of the reaction and periodically 
squeezing (gently) blowing oxygen against the side of the reaction flask causing a 
gentle bubbling worked well. Placing the needle into the solution and aggressively 
bubbling oxygen into the solution also works reasonably well, but it is not 
recommended. If you are attentive with the oxygen you will achieve much better 
yields of 1c, although not the reported 81%.  
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It was envisaged that the side product could shed light on the significantly 
reduced yield of 1c and the slow reaction times. Following isolation by column 
chromatography, the side product appeared as a colourless free flowing liquid, 
which when developed on a TLC plate using anisaldehyde as a stain appeared red 
in colour. 
After spectroscopic analysis, NMR (
1
H & 
13
C) and ESI-MS, the side product was 
found to be ethylene glycol monoacetate (1f), as shown in Figure 30. 
 
 
 
Figure 30 Structure of glycol monoacetate (1f) 
 
Acetate 1f was clearly a fragmentation product of methyl dioxolane 1a. A 
plausible sequence leading to the formation of 1f is shown below (Figure 32), as 
is the mechanism of dioxolane fragmentation (Figure 31). 
 
 
 
Figure 31 Mechanism of methyl dioxolane fragmentation 
 
The fragmentation of dioxolane from structure 1h is shown in the following 
scheme (Figure 32). 
34 
 
 
 
Figure 32 Fragmentation of methyl dioxolane. 
 
A control reaction was devised to establish what was causing the formation of the 
side product. The same conditions as before were used except the absence of 
methyl acrylate from the reaction mixture; after nine hours of vigorous stirring at 
room temperature, a 45% yield of ethylene glycol monoacetate was obtained, 
which increased to 86% if the reaction was left overnight. It was rationalised that 
possibly MEHQ inhibitor present in the acrylates was affecting the selectivity and 
allowing the radical fragmentation to time to compete effectively with the 
intended intermolecular radical addition. 
 
To see if the was the case; methyl acrylate (1b) was run through a pipette of 
alumina which removed the inhibitors present. The reaction was performed again 
with the inhibitor free methyl dioxolane, which gave a vast improvement in the 
yield of 1c, after 6-7 hours it was isolated in 60% yield. However efforts to 
replicate Ishii’s yield of 81% for 1c within the same time frame reported, were 
unsuccessful. 
1h 
Reduction Fragmentation 
H-abstraction 
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The reaction successfully showed that PINO is able to abstract a hydrogen atom 
from dioxolane 1a and generate a carbon-centred radical. Consequently it was 
decided to move on and explore the use of this methodology to mediate 
intramolecular reactions. 
 
2.2 Synthesis of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone (2a) and 
Subsequent Cyclisation Attempts 
 
Having confirmed that PINO has potential to be used as an initiator of carbon-
centred radical reactions, a model compound was selected (2a) to investigate 
cyclisation reactions (Figure 33). 
 
 
 
Figure 33 Structure of 1-(2,5-dihydro-pyrrol-1-yl)-3-phenyl-propenone 
 
It was envisaged that PINO would abstract a hydrogen atom from the NCH2C 
group of 2a to form a (NCH•C) radical (Figure 34). This resonance-stabilised 
radical could then undergo an intramolecular cyclisation. A 4-exo-trig cyclisation 
is possible or alternatively a 5-endo-trig cyclisation (as shown in 2b), generating 
radical species 2c, which after trapping with molecular oxygen and reduction of 
the hydroperoxide was expected to give pyrrolizidone like structures 2d. 
2a 
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Figure 34 5-endo-trig cyclisation of 2b 
 
Having selected a suitable model compound to explore this chemistry, it was 
necessary to first synthesise 2a. A RSA of the proposed route to 2a is shown in 
Figure 35. 
 
 
Figure 35 Retrosynthetic analysis of 2a 
 
2.2.1 Synthesis of N, N-Diallyl-3-phenyl-acrylamide (3c) 
 
 
Figure 36 Acylation of diallylamine with cinnamoyl chloride 
2b 2c 2d 
3a 3b 3c 
Metathesis Acylation 
2a 
Et3N (3 equiv) 
Argon 
DCM (dry) 
0 
o
C 
37 
 
The acylation of diallylamine
43
 (3a) with cinnamoyl chloride (3b) was performed 
under anhydrous conditions (Figure 36). A flame-dried round-bottom flask and an 
argon atmosphere were used, into which anhydrous DCM was injected followed 
by diallylamine (3a). In a separate oven-dried round-bottom flask, cinnamoyl 
chloride (3b) was dissolved in dry DCM. Triethylamine (dry) was then injected 
into solution, which was cooled using a water-ice bath. Once the solution was 
sufficiently cold, the acyl chloride solution was added dropwise (via syringe) into 
the chilled solution.  
After the addition was complete, the ice bath was removed and the solution was 
allowed to warm to room temperature. After 5 hours, water was added and the 
mixture worked up. The product (3c) was isolated as yellow oil, in an average 
(62-70%) yield of 67%. The reaction and purification presented no issues; it was a 
relatively straight-forward procedure. 
 
2.2.2 Synthesis of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone (2a) 
 
 
 
Figure 37 Grubbs metathesis of 3c to 2a 
 
3c 2a 
Toluene (dry) 
Argon, reflux, 6 hr 
2nd Gen. Grubbs cat. 
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After successfully preparing 3c, a metathesis reaction was used to form 2a (Figure 
37.). The reaction required optimisation to achieve satisfactory yields. 
 
Initially a 2
nd
 generation Grubbs catalyst
44
 was used in dry DCM but the yield of 
2a was surprisingly poor. Next, two different solvents, dry MeCN or dry toluene, 
were investigated. The first performed equally poorly but the toluene performed 
much better, to give 2a as a white powder in 62% yield. After purification, it is 
recommended to store 2a under argon in a sealed vial in the fridge; it was found 
that it decomposes slightly over the space of a couple of weeks and turns from a 
white powder into an orange one. 
 
 
Figure 38 Failed cyclisation of 2a using Ishii system 
 
Attempts at using Ishii’s methodology40 to cyclise 2a (Figure 38), to form 2d, 
were not successful. The first problem encountered was the limited solubility of 
NHPI in various solvents at room temperature. Acetic acid was chosen as solvent, 
as not only did it dissolve NHPI, but numerous papers claimed it enhanced Ishii’s 
chemistry.
45
 
 
At room temperature, unfortunately, there was no reaction. On increasing the 
temperature of the reaction nothing was observed until 100 
°
C; analysis of the 
2a 2d 
 cat. NHPI 
 cat. Co(OAc)2 
O2, heat 
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reaction mixture by TLC, however, was extremely complex despite efforts to 
isolate anything from the mixture using column chromatography. It was apparent 
that compound 2a was not reacting in a controllable manner. It was, however, 
stable in acetic acid at 100 
°
C and so it was not degrading under the reaction 
conditions. It was eventually decided that the model compound 2a needed to be 
re-redesigned to increase the reactivity to hydrogen atom abstraction. 
 
2.3 Synthesis of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one and 
Subsequent Cyclisation Attempts. 
 
The redesigned compound (4a) was chosen as the N-CH2 hydrogen atoms were 
anticipated to be particularly susceptible to hydrogen-atom abstraction, due to 
increased radical stability by the presence of an aromatic ring and an additional 
carbonyl group (Figure 39). 
 
 
Figure 39 Structure of 2-(3-phenyl-acryloyl)-2, 2-dihydro-isoindol-1-one 
 
It was envisaged that PINO would abstract a hydrogen atom from the NCH2C 
group of 4a to form radical, 4b (Figure 40). A 4-exo-trig cyclisation of 4b is 
possible, or alternatively a 5-endo-trig cyclisation (as show below), generating 
4a 
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radical species 4c, which after trapping with molecular oxygen, and reduction of 
the hydroperoxide was expected to give pyrrolizidinone-like structure 4d. 
   
 
Figure 40 5-endo-trig cyclisation of 4b 
 
2.3.1 Synthesis of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one (4a) 
 
It was envisaged that 4a could be prepared by N-acylation of 5b (Figure 44). The 
first route to iso-indolinone 5b involved reduction of phthalimide 5a using tin and 
acid (Figure 41). This old fashioned method
45
, involving suspending both 
phthalimide 5a and an excess of tin in a 2:1 solution of HCl and acetic acid, and 
heating to reflux for 2 hours worked well. The yield of 5b varied but on average 
was 55%. The compound was (unexpectedly) yellow, but it was not possible to 
remove the colouration (possibly due to contamination with a tin-containing 
impurity). 
 
   
 
Figure 41 Phthalimide reduction to iso-indolinone 
4b 4c 4d 
5a 5b 
HCl/CH3COOH 
Sn 
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The requirement for an excess of tin and the impurity causing the yellow colour, 
caused concern and it was decided to pursue a completely different synthetic 
route
47
 as shown in Figure 42 
 
 
 
Figure 42 One-pot synthesis of iso-indolinone 
 
Compound 5c was manufactured from phthalide (5e), which was dissolved in 
xylene along with benzyltriethylammonium chloride and treated with BF3-etherate 
complex. The mixture was refluxed at 100 
°
C and thionyl chloride was added very 
slowly over one hour, and then refluxed at 130 
°
C for 9 hours. The excess solvent 
was distilled off along with residual thionyl chloride under reduced pressure. 
Purification gave compound 5c as a clear liquid in 90% yield. 
This reaction proved very easy to scale up and gave 5c in high yields. This was 
important as the next step was shown to be low-yielding. By manufacturing large 
quantities of 5c, it was possible to circumvent this short-coming. 
 
The next step involved the one pot synthesis of iso-indolinone 5b from 5c, by first 
generating an intermediate ester (5d), by refluxing 5c in ethanol for 1 hour and 
then cooling before adding slowly ammonium hydroxide. Compound 5d 
undergoes an intramolecular lactamisation to give 5b (Figure 43). The solution 
turned a light orange colour initially then a light yellow when the reaction was 
complete.  
5c 5d 5b 
EtOH NH3 SOCl2 
5e 
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After the reaction had finished the reaction mixture was extracted with 
dichloromethane. The combined extracts were dried with anhydrous Mg2SO4, the 
solvent was evaporated in vacuo and the residue was recrystallized from benzene 
(or alternatively toluene) to give iso-indolinone 5b in 38% yield, as fine clear 
needle crystals.  Although modest, the 38% yield can be increased when using an 
ammonia gas cylinder, saturating an ethanol solution of 5c with ammonia gave 
80% yield of 5b. The mechanism of the reaction of 5d with ammonia, to form iso-
indolinone 5b is shown in Figure 43. 
 
 
Figure 43 Intramolecular lactamisation mechanism. 
 
 
 
 
5d 6b 
6c 
6d 6e 5b 
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2.3.2 Synthesis of 2-(3-Phenyl-acryloyl)-2, 2-dihydro-isoindol-1-one (4a) 
 
The next step in the synthesis of 4a was straight-forward
48
 (Figure 44). 
 
 
Figure 44 Synthesis of 2-(3-phenyl-acryloyl)-2,2-dihydro-isoindol-1-one 
 
Sodium hydride in anhydrous DCM was added to a solution of iso-indolinone 5b 
in dry DCM.  The flask was cooled in a water/ice bath, and a solution of 
cinnamoyl chloride 7a in DCM was slowly injected into the flask over a period of 
30 minutes. The reaction was left to stir for 24 hours, after which a white solid 
was obtained. Re-crystallisation with benzene gave thin white fluffy needles of 4a 
in a 66% yield. 
 
 
 
Figure 45 Failed cyclisation of 4a using the Ishii system 
 
5b 7a 4a 
4a 4d 
O2, heat 
 cat. NHPI 
 cat. Co(OAc)2 
NaH (60%) 
DCM (dry) 
 0 
o
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Treating 4a with NHPI in acetic acid was investigated at room temperature but 
surprisingly no reaction was observed (Figure 45). Successive attempts of varying 
the amount of catalyst, the temperature and the allotted time, did not result in a 
reaction. The reason for the lack of success is unknown and worthy of further 
investigation. 
 
The research then moved on from Ishii’s work, to investigate the radical 
cyclisation of 4a using a different nitroxide-based C-C bond forming reaction. 
Interestingly, in the literature, TEMPO had been shown to couple nitromethane to 
acridine (Figure 46).
49
 
It was envisaged that an acridine and 4a would have comparable reactivity to 
hydrogen abstraction. 
 
Figure 46 Coupling of nitromethane to an acridine using TEMPO catalyst 
 
Initially the reported chemistry was replicated. This first involved the synthesis of 
10-methyl-9,-10-dihydroacridine (8c)
 50
, via 8b, as shown in Figure 48. 
 
 
Figure 47 Quinoline reduction 
8a 8b 
 TEMPO 10% 
Nitromethane 
O2, RT 
BF3.O(Et)3 
NaBH3CN 
THF, 8 hr 
110 
o
C 
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Compound 8b was prepared by reacting a solution of quinoline 8a, sodium 
cyanoborohydride and boron trifluoride etherate in dry THF at reflux for 8 hours. 
Purification of the crude product by silica gel column chromatography furnished 
the desired product in 65% yield (Figure 47). 
 
Next acridine 8c was formed by N-methylation of 8b
51
 (Figure 48). Following 
deprotonation of 8b using n-butyllithium in dry THF, iodomethane was added to 
give 8c in 91% yield as a white solid. 
 
  
 
Figure 48 N-Methylation of 8b 
 
Next a solution of 10-methyl-9,10-dihydroacridine and TEMPO was stirred at 60 
°
C under O2 (1atm) for 18 hours. The solvent was removed and the residue was 
purified by silica gel column chromatography to afford the desired product in 92% 
yield as a red solid (Figure 49) 
 
Figure 49 Successful coupling of nitromethane to 8c 
8b 
8c 
8c 
8d 
 TEMPO 10% 
Nitromethane 
O2, RT 
THF, RT, 12 hr 
n-BuLi, MeI 
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The 
1
H NMR spectrum of compound 8d (Figure 50 and 117) shows a triplet at 
7.28 ppm which integrates to two protons (J = 7.8 Hz), a doublet at 7.21 ppm 
which integrates again to two protons (J = 6.8 Hz) and further along a multiplet at 
6.95-6.99 ppm which integrates to four protons. These protons make up 
collectively the eight aromatic protons. The four protons at 6.95-6.99 ppm are 
likely to be the protons on the aromatic ring. The triplet at 4.79 ppm (J = 8 Hz) 
integrates to one, this proton is attached to C1 (31.2 ppm). The doublet at 4.33 
ppm (C3, J = 8 Hz) integrates to two, this is the CH2 directly next to the nitro 
group. The singlet at 3.40 ppm integrates to three, which is the methyl group. 
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Figure 50 
1
H NMR spectrum of (8d) at 400 MHz in CDCl3 
 
Pleased that the procedure worked as reported, the same reaction conditions were 
then applied to 4a (Figure 50). Unfortunately 4a failed to react, even when 
stoichiometric amounts of TEMPO were used. 
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Figure 51 Attempted reactions of 4a with mitromethane 
 
After exhausting these options, attention turned to the use of N-bromosuccinimide 
(NBS)
52
 to see if it would perform any radical chemistry on the stubborn 4a 
(Figure 51). Thankfully for the first time, this combination resulted in some 
activity. 
 
 
 
 
Figure 52 Formation of hydroxyl-lactam 9b 
 
To a solution of 4a and AIBN in EtOAc, NBS was added and the reaction was 
refluxed for 12 hours. Purification of the reaction mixture by column 
chromatography resulted in the formation of 9b as a white solid in an excellent 
80% yield. 
4a 8e 
4a 9b 
 NBS 
AIBN 
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NMR spectroscopic analysis showed that the NCH2 peak in 4a had vanished, 
which was great news. A combination of ESI and NMR convincingly showed that 
the product was 9b. 
 
 
 
Figure 53 Mechanistic explanations for hydroxyl-lactam formation 9b 
 
A possible mechanism to form 9b (Figure 53) involves the formation of bromide 
9a, presumably via a benzylic radical. Bromide 9a is rapidly hydrolysed into the 
alcohol on workup. This reaction finally showed that a NCH2 hydrogen atom 
could be abstracted, although there was no cyclisation. This led to redesigning the 
precursor once again, this time extending the carbon chain and removing steric 
bulk in the hope that the intermediate benzylic radical would cyclise onto the 
terminal C=C bond of 10a (Figure 54) 
 
 
 
Figure 54 Structure of 2-but-3-enyl-2,3-dihydro-indol-1-one (10a)  
4a 9a 9b 
 NBS 
AIBN 
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2.4      Synthesis of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) and 
Subsequent Cyclisation Attempts  
 
 
Figure 55 N-Alkylation of 5b using caesium carbonate 
 
To prepare 10a, iso-indolinone 5b was N-alkylated using caesium carbonate
53
 and 
4-bromobut-1-ene at 80 
°
C (Figure 55). Purification by column chromatography 
afforded 10a as a yellow oil in 79% yield. The product was analysed by ESI and 
NMR spectroscopic analysis. The product has the formula C12H13NO, which is 
consistent with the structure of 10a (Figure 54). The 
1
H NMR is shown below 
(Figure 56). 
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Figure 56 
1
H NMR spectrum of compound 10a (400 MHz, CDCl3) 
5b 10a 
BrCH2CH2CH=CH2 
          MeCN 
           reflux 
Cs2CO3 
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The aromatic protons of 10a consist of the doublet at 7.81 ppm which integrates 
to one (J = 8.34 Hz), the multiplet at 7.47-7.52 ppm integrates to one proton and 
the multiplet at 7.40-7.44 ppm) which integrates to two protons. The multiplet at 
5.75-5.87 ppm integrates to one proton bonded to C11 (141.2 ppm) and is the 
allylic CH. The multiplet at 5.00-5.11 ppm integrates to two protons which are 
bonded to C4 (117.2 ppm) and is the terminal allylic CH2 of 10a. The singlet at 
4.37 ppm integrates to two protons and is bonded directly to C3 (50.2 ppm) and is 
the CH2 of the lactam adjacent to the nitrogen. The multiplet at 3.66-3.70 ppm 
integrates to two protons and is bonded directly at C2 (42 ppm) position, the first 
carbon of the unsaturated chain bonded to the nitrogen. The multiplet at 2.39-2.45 
ppm integrates to two protons which are bonded to C1 (33 ppm).  
 
Now that 10a was readily available, it was envisaged that reaction with NBS 
would lead to 10e by the mechanism shown in Figure 57. 
 
 
 
Figure 57 Proposed NBS-mediated cyclisation 
 
First 10a in EtOAc was reacted with NBS and AIBN; during reflux an orange 
insoluble gel started to collect on the sides of the flask. The reaction did not reach 
completion after 5 hours; TLC analysis showed four new products had formed, all 
10a 10c 
10d 10e 
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UV active. On cooling the mixture, succinimide precipitated out of the solution. 
The crude product was subject to column chromatography on silica gel and 
products 11a-d were isolated (Figure 58). Unexpectedly, 6-ring compound 11a 
was formed. 
 
 
 
Figure 58 Resulting products of NBS reaction, successful cyclisation 
 
Compound 11a is a light yellow solid isolated in 4-6% yield; 11b is sticky oil 
(orange) isolated in 31% yield, 11c is a yellow crystalline solid isolated in 36% 
yield; and 11d is a white solid isolated in 27% yield. Although the yield of 11a 
was low, it was very pleasing to see the formation of cyclised product 11a. A 
possible mechanism to explain the formation of 11b, involving double 
bromination and hydrolysis is shown in Figure 59. 
 
10a 
11d 11b 11c 11a 
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Figure 59 Mechanistic explanations for maleimide formation 
 
The products were analysed using ESI-MS and NMR spectroscopic analysis.  
Compound 11c has the formula C12H11Br2NO2.  This suggested the compound had 
been brominated and had acquired and addition oxygen atom.  The 
1
H NMR 
spectrum below (Figure 60) suggested a compound that has symmetric aromatic 
protons and the CH2 of the starting material (10a) was no longer present. 
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Figure 60 
1
H NMR spectrum of compound 11c (400 MHz, CDCl3) 
10a 12a 12b
 
 11a 
11b 
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The 
1
H NMR spectrum of 11c shows a multiplet at 7.85-7.88 ppm, which 
integrates to two protons. Another multiplet which integrates to two protons is 
found at 7.72-7.74 ppm. The complex multiplet at 4.12-4.21 ppm integrates to one 
and by using HSQC is bonded to C4 at 48.8 ppm. The complex multiplet at 3.84-
3.99 ppm integrates to three, two protons are bonded directly onto C3 (36 ppm) 
and one to C2 (35 ppm). The triplet at 3.64 ppm integrates to one and is also 
bonded to C2. The multiplet at 2.53-67 ppm integrates to one, and is bonded 
directly to C1 (34.9 ppm) the multiplet at 2.13-2.23 ppm is also bonded directly to 
C1. 
This data along with COSY interactions strongly supported the structure of 11c 
with the double bond being brominated and the CH2 being oxidised to a 
maleimide in the same way 11b was in Figure 59. 
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Figure 61 
1
H NMR spectrum of compound of 11d 
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Spectroscopic analysis of compound 11d revealed the formula C12H12BrNO3, 
having one less bromine atom than 11c and an extra oxygen and hydrogen atom.  
The 
1
H NMR spectrum of compound 11d is shown (Figure 61), the aromatic 
region similar to 11c which indicates it is a maleimide.  The double of doublets at 
7.82-97 ppm integrates to two protons (J= 3, 8.59 Hz). The double of doublets at 
7.70-75 ppm also integrates to two (J= 3, 8.54 Hz). The double of doublets at 
3.85-91 ppm integrates to two protons (J= 3, 7.63 Hz), HSQC indicates that one 
proton is bonded to C1 (34.2 ppm) and the other to C3 (38.9 ppm). The multiplet 
at 3.80 ppm integrates to one proton and bonded to C4 (68.5 ppm). The multiplet 
at 3.46-51 ppm integrates to one proton and bonded to C2 (34.7 ppm). The 
multiplet at 3.39-44 ppm integrates to one proton is also bonded to C2. The 
multiplet at 3.09 integrates to one proton, does not bond to a carbon suggesting 
that it is attached to oxygen. The multiplet at 1.91-2.00 ppm integrates to one 
proton and is bonded to C1. The multiplet at 1.80-1.89 integrates to one proton 
and is bonded to C3. Compound 11d therefore has a hydroxyl group at the C4 
position. This data along with data from COSY interactions strongly supported the 
structure of 11d. 
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Figure 62 H
1
 NMR spectrum of 11a (400 MHz, CDCl3) 
 
The 
1
H NMR spectrum of 11a is shown in Figure 62. The aromatic structure was 
intact (Figure 63) and the CH2 singlet (δ 4.35) in 10a was no longer visible. 
Integration revealed 12 hydrogens consistent with the molecular structure of 11a. 
ESI confirmed the molecular formula as C12H12BrNO. Interestingly only a single 
isomer of 11a was formed as indicted by single resonances in the spectrum, the 
stereochemistry of which is unknown. All the protons have been assigned letters, 
and their chemical shifts and COSY interactions are listed in Table 1. Initially it 
was not possible to confidently assign the structure of 11a due to the quality of the 
2D NMR spectra, the COSY interactions were only of acceptable quality. 
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Proton δ (ppm) App. Int. J(Hz) COSY 
A 7.88 d 1 7 HC 
B 7.55 t 1 7 HD 
C 7.49 t 1 7 HA 
D 7.43 d 1 7 HB 
E 4.84 dd 1 11,3 HL. HI 
F 4.80 br s 1 - HJ, HI 
G 4.46 dd 1 14,5 HK, HH 
H 3.49 td 1 15,3 HK,HJ, HG 
I 2.69 d 1 13 HL,HE(w), 
HF(w) 
J 2.17 d 1 14 HK,HH 
K 1.91 m 1 - HH, HG,HJ 
L 1.61 ddd 1 14,11,3 HI, HE, 
HF 
 
Table 1 Tabulated NMR Data for 11a (400 MHz, CDCl3, 20 
o
C) 
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Figure 63 
1
H-NMR (400 MHz, CDCl3) 
 
A 
B 
C D 
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The aromatic protons (A-D) resonate at 7.43-7.88 ppm, and collectively integrate 
to four (Figure 63). The doublet at 7.88 ppm (proton A, J = 7 Hz) has a COSY 
cross peak with proton C. The triplet at 7.55 ppm (proton B, J = 7 Hz) has a 
COSY cross peak with proton D. The triplet at 7.49 ppm (proton C, J = 7 Hz) has 
a COSY cross peak with proton A. The doublet at 7.43 ppm (proton D, J = 7 Hz) 
has expected COSY cross peak with proton B.  
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Figure 64 
1
H-NMR (400 MHz, CDCl3) 
The double of doublets at 4.84 ppm (Figure 64) integrates to one (proton E, J = 
11, 3 Hz), COSY cross peaks (see Table 1) suggest it couples to  two protons, L 
(ddd, 1.61 ppm) and I (d, 2.69 ppm). The broad singlet at 4.80 ppm (Figure 64) 
intergrates to one (proton F) and COSY interactions suggest it weakly couples to 
protons J (d, 2.17 ppm) and I. The double doublet at 4.46 ppm (Figure 64) 
integrates to one (proton G, J = 14, 5 Hz) and COSY interactions suggested it 
couples strongly with proton H (3.49 ppm) and K (1.91 ppm). The triple doublet 
at 3.49 ppm (Figure 64) integrates to one (proton H, J = 15, 3 Hz) and COSY 
interactions suggest it couples with protons K (1.91 ppm), J (2.17 ppm) and G 
E &F 
G 
  A 
H 
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(4.46 ppm). The doublet at 2.69 ppm (Figure 65) integrates to one (proton I, J = 
13 Hz) and has a stong COSY interaction with proton L (2.17 ppm) and two weak 
interactions with protons E (4.84 ppm and F (4.80 ppm). Proton J at 2.17 ppm 
(Figure 65) integrates to one (J = 14 Hz) has COSY interactions with protons K 
(1.91 ppm) and H (3.49 ppm). The multiplet at 1.91 ppm (Figure 65) integrates to 
one (proton K)  has COSY interactions with proton H, G and J. Proton L at 1.61 
ppm (Figure 65) integrates to one (J = 14, 11, 3 Hz) has COSY interactions with J, 
E and F. 
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Figure 65 
1
H-NMR spectrum of 11a (400 MHz, CDCl3) 
 
Because the other 2D experiments (HSQC and HMBC) were of poor quality, it 
was not possible to categorically say what structure was present. But the 
combination of results of ESI and 
1
H
 
NMR suggested that a cyclic product had in 
fact been made. 
 
Encouraged by the success with NBS in producing a cyclic structure it was 
decided to compare the reactivity of 10a with NIS (Figure 66). The reaction was 
I 
J 
K 
L 
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very much the same as before. Purification by column chromatography gave 13a 
as a diastereomeric mixture, as a light pink solid in 8-9% yield; 13b as sticky oil 
in 39% yield; 13c as a pink/red solid in 24% yield; and 13d as a white solid in 
29% yield. Pleasingly another cyclic compound was formed, this time as a 
mixture of diastereomer and in higher yields. 
 
 
 
 
Figure 66 Resulting products of NIS reaction, successful cyclisation 
 
Running the sample again on 400 MHz spectrometer, produced the H
1
 spectrum 
(Figure 67).  
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Figure 67 1H NMR spectrum of 11a (400MHz, CDCl3) 
10a 13a 13b 13c 13d 
 NIS 
AIBN 
EtOAc 
80 
o
C 
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It was clear that there was a diastereomeric mixture of compounds; ESI showed a 
complementary formula (C12H12INO) to compound 11a. Unfortunately the 2D 
NMR experiments were not of sufficient quality to tease out the information need 
for unambiguous assignment. It was decided to run the sample again, this time on 
a 700 MHz machine, to obtain a higher resolution spectrum. 
 
This proved much more successful, the HSQC data showed which protons were 
bonded to what carbon and a TOCSY experiment was used to identify which 
proton belonged to which diastereomer. A TOCSY experiment observes cross-
peaks not only nuclei directly coupled (like a COSY) but nuclei connected by a 
chain of couplings. By identifying the interconnected networks of spin couplings, 
it was easier to differentiate the protons belonging to each diastereomer.  
 
One diastereomer shared very similar features to the NBS product (Figure 68). As 
it was not possible to obtain good 2D spectra of the NBS derived product, if the 
NIS derived product (diastereomer 1) can be assigned the structure of the NBS 
derived cyclic product could be inferred. 
 
Figure 68 Comparison of 11a with 13a (400 MHz) 
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The COSY, HSQC and HMBC data of each proton and carbon of diastereomer 1 
(13a) are displayed in Tables 2 and 3. 
 
The COSY interactions for each proton are shown magnified in spectra 43-45, the 
interactions are virtually identical to the COSY interactions seen in 11a, just 
better resolution.  
 
The HSQC data revealed that the molecule consists of three CH2 groups and two 
CH groups. C3 is bonded to protons G and H, C2 is bonded to K and J, C4 is 
bonded to L and I and C5 bonded to F and finally C1 bonded to E. C1 has the 
lowest chemical shift and is assumed to be linked to iodine. Using the COSY 
interactions it was possible to determine the locality of the protons to each other 
and therefore to assign the ring system displayed (Figure 65). 
As the 700 MHz spectrometer helped establish the presence three CH2 groups, 
this compound cannot possibly be the 5-membered ring (10e). Hence the 6-
membered ring is formed as shown in Figure 69. 
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Figure 69 Structure of diastereomer 1 (13a) 
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Figure 70 Structure of diastereomer 2 (13a) 
 
The tabulated data for diastereomer 2 (Figure 70) can be found in the appendices 
(Tables 4 and 5). 
 
 
Figure 71 Proposed cyclisation mechanism of 10a to 11a. 
 
It appears that the (NCH•) radical does not cyclise but instead gets oxidised to a 
NCH
+
 cation by single electron transfer with another radical or bromine molecule. 
This cation adds to the double bond to form a cyclic cation which reacts with Br
-
 
to yield the final product (Figure 71). 
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Proton δ(ppm) App. Int. J(Hz) COSY HSQC HMBC 
A 7.87 d 1 7 HC C7 C9, C11, 
C12 
B 7.54 t 1 7 HD C9 - 
C 7.47 t 1 7 HA C8 C10, C6, 
C12 
D 7.41 d 1 8 HB C6 C8, C10, C5 
E 4.90 br s 1 - HI,HJ,HK,HL C1 C2(w)C3, 
C4, C5 
F 4.78 dd 1 11,3 HL, HI C5 C1, 
C4,C6(w), 
C10(w), 
C11, C12 
G 4.46 dd 1 14,4 HK, HH C3 C1,C2,C5, 
C10(w), C12 
H 3.38 td 1 15,3 HK,HJ,HG C3 C1,C2,C12 
I 2.64 d 1 13 HL, HE, HF C4 C1,C2,C5(w) 
J 2.12 d 1 15 HL, HH, HE C2 - 
K 1.65 m 1 - HJ, HH, HG, 
HE 
C2 C3(w) 
L 1.35 ddd 1 14,12,3 HI,HF, HE C4 C5(w), 
C11(w) 
 
 
Table 2: Tabulated results for diastereomer 1, (13a) (700 MHz, CDCl3, 20 
o
C) 
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Table 3: Tabulated results for diastereomer 1 (13a) (700 MHz, CDCl3, 20 
o
C)  
 
 
 
 
 
 
 
 
 
 
 
 
Carbon δ (ppm) HSQC HMBC 
1 29.2 HE HF, HG, HH, HI 
2 34.7 HK HE(w), HG, HH, HI 
3 36.7 HG, HH HE, HJ(w) 
4 41.0 HI, HF HE, HF 
5 55.9 HF HD, HE, HG, HI(w), HL(w) 
6 121.0 HD HC, HF(w),  
7 124.1 HA - 
8 128.5 HC HD 
9 131.5 HB HA 
10 132.4 - HC, HD, HF(w),HG(w) 
11 144.8 - HA,HF 
12 166.0 - HA,HC,HF,HG,HH 
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Chapter Three: Concluding Remarks 
 
Although Ishii’s chemistry was reproducible it proved to be ineffective as an 
alternative radical initiator of intramolecular cyclisations, but a new competitive 
radical fragmentation pathway was identified in the reaction of an acetal under 
Ishii’s reaction conditions.  
 
Other nitroxides such as TEMPO have been shown to be successful performing 
carbon-carbon bond forming reactions between acridines and nitromethane but 
unable to couple nitromethane to target lactams 4a and 10a or induce 
intramolecular cyclisations.  
 
Interestingly reactions of lactams bearing unsaturated-chains, with NBS or NIS, 
were shown for the first time; to afford cyclic products. In competition with 
cyclisation, was the formation of maleimides and/or hydroxy-lactams derived 
from oxidation adjacent to nitrogen. 
 
Maybe I was unfortunate with my substrate choice when I initially began 
exploring the potential of the PINO radical to initiate radical cyclisations. With an 
alternative and more activated substrate there could have been greater success. 
But from what I have observed, PINO has been unsuccessful and surprisingly so. 
 
Fortunately a new and unreported cyclisation pathway has been identified, albeit a 
low yielding pathway. This novel N-halosuccinimide cyclisation technology 
constructs cyclic architectures of med-chem importance and crucially without the 
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requirement for tin or other toxic metals. Although currently a low yielding 
reaction it has revealed a potential, which future researchers could build upon.  
 
Future work could explore the use of alternative reaction conditions for the 
NBS/NIS reactions, and alternative substrates bearing different unsaturated side-
chains (e.g. electron-poor C=C bonds). Alternative, non-metal oxidants could also 
be explored, including NCS.  
 
Unfortunately due to time constraints additional lactams that were synthesised 
(detailed in experimental section), I did not have the opportunity to explore the 
reactivity. They were synthesised with the intention of developing an 
intramolecular carbon-carbon bond forming radical reaction. By screening the 
reactivity of these lactams, it would provide further insight towards developing an 
intermolecular cyclisation methodology. 
 
However the aim of developing an alternative clean radical cyclisation technology 
has not been achieved. The search for an environmentally benign alternative to tin 
radical cyclisation technology continues. I hope in some small way I have 
contributed to this search and that my findings help others in their future radical 
endeavours. 
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Chapter Four: Experimental Section 
 
4.1 Synthesis of Methyl-2-hydroxy-3-(2-methyl-1,3-dioxolan-2-yl) propanoate 
(1c)
40 
 
O
O
CH3
CH2
O
OCH3
O O
CH3
OH
O
O
CH3
+
cat. NHPI
  cat. Co(OAc)2
O2, RT
3 hr
 
 
A solution of methyl dioxolane (1.32g, 15mmol), NHPI, (25mg, 0.15mmol) and 
Co(OAc) 2 (3mg, 0.0015mmol) in a two necked flask was equipped with a balloon 
filled with oxygen. To this solution methyl acrylate (258mg, 3mmol), was injected 
slowly. The acrylate must be run through an alumina column to remove MEHQ 
inhibitor prior to addition and methyl dioxolane must be thoroughly purged with 
oxygen. The method of delivery of the oxygen is important; the needle should go 
into the solution and periodic aggressive bubbling of oxygen over the duration of 
the reaction is needed to achieve a satisfactory yield of 61% (347mg). Remove the 
excess dioxolane on a rotary evaporator, leaving a clear liquid after purification 
using column chromatography (2:1 EtOAc:Hex, rf: 0.37). 
Running the reaction without removing the MEHQ inhibitor reduces the yield of 
1c to 33% (190 mg) and takes significantly longer for the reaction to begin (9hr+) 
and encourages the significant production of a side product, ethylene glycol 
monoacetate (0.150 mg, rf: 0.25).  High-resolution mass spectroscopy (ESI): 
(M+H)
 +
: for (1c) C8H14O5, 191.9102; (1f) C4H8O3, 105.4731. 
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Methyl-2-hydroxy-3-(2-methyl-1,3-dioxolan-2-yl) propanoate (1c) 
 
5
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 4.40 (m, 1H, A), 3.99 
(m,4H, B), 3.76 (s, 3H, C), 3.69 (br m, 1H, D), 2.28 (1H, E), 2.15 (1H, F), 1.38 (s, 
3H, G).
13
C-NMR (400 MHz, CDCl3): δ = 174.0(7), 109.2(6), 67.7(5), , 64.0(4), 
51.8(3), 41.4(2), 24.0(1).  
 
Ethylene glycol monoacetate (1f) 
O
3
2
O41
O
H
C
H
B
H
B
H
A
H
A
H
D
H
D H
D
 
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 4.31 (t, 2H, J= 7 Hz, A), 
4.18 (t, 2H, J= 7 Hz, B), 2.30 (br, 1H, OH, C), 2.01 (s, 3H, D).
13
C-NMR (400 
MHz, CDCl3): δ = 179.0(4), 72.0(3), 61.92(2), 18.1(1) 
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4.2 Synthesis of 9,10-Dihydro-acridine (8b)
 50
 
 
N N
H
BF3· O(C2H5)2
NaBH3CN
THF, 8 hr
110 oC
 
A  solution  of  a  quinoline  (0.5  mmol),  sodium  cyanoborohydride  (1  mmol)  
and  boron  trifluoride etherate  (5  mmol)  in  dry THF  (2  ml)  was  refluxed  for 
8h. The  reaction  mixture  was  cooled,  treated  with  25  % aqueous  ammonia (5 
ml)  and  extracted  with  diethyl-ether (3 x 5 ml).  The  ether  extract  was  
washed  with  brine  and  dried  over anhydrous  sodium  sulfate. Evaporation, of  
the solvents  followed  by  purification  of the  residue  over  a  silica  gel  column 
(hex:toluene 1:1, Rf:0.34) furnished   the  product in 60% yield.  
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.07-7.13 (m, 4H, A), 6.84-
6.89 (m, 2H, B), 6.68 (d, J= 7.9 Hz, 2H, C), 5.96 (br s, 1H), 4.07 (s, 2H). 
13
C-
NMR (400 MHz, CDCl3): δ = 31.5(1), 113.5(2), 120.1(3), 120.7(4), 127.0(5), 
128.8(6), 140.2(7). 
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4.3 Synthesis of 10-Methyl-9,10-dihydro-acridine (8c)
 51
 
 
N
H
N
CH3
BuLi (1.1 equiv)
MeI (1.0 equiv)
THF, rt
12 hr
 
An oven dried round bottom flask equipped with a magnetic stirrer was evacuated 
and refilled with argon, then charged with a solution of acridine (544mg, 
3.0mmol) in THF (20ml). A solution of n-BuLi (2.5M in hexanes, 3.3ml) was 
added dropwise at 0-5
0
C for 2 hr and RT overnight. The reaction was then 
quenched with water (30ml) and the product extracted with EtOAc (3x30ml). The 
organic layers were combined and washed with brine and dried over MgSO4, 
filtered and concentrated in vacuo. The crude was columned on silica (hex:toluene 
1:1 v/v) to afford 533 mg (91%) of a white solid. 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.18-7.26 (m, 4H, A), 6.90-
6.98 (m, 4H, B), 3.92 (s, 2H, C), 3.4 (s, 3H, D). 
13
C-NMR (400 MHz, CDCl3): δ = 
33.2(1), 33.3(2), 112.0(3), 120.6(4), 124.4(5), 127.0(6), 127.6(7), 143.8(8). 
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4.4 Synthesis of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine (8d)
 49 
N
CH3
N
CH3
NO2
TEMPO (10%)
Nitromethane
O2, 60 °C
AcOH
 
 
A solution of 10-methyl-9, 10-dihydroacridine (39.5 mg, 0.2 mmol) and TEMPO 
(3.2 mg, 0.02 mmol) was placed in a 25 mL round bottom flask. Then CH3NO2 
0.5 mL was added. The reaction mixture was stirred at 60 ℃ under O2 (1 atm) for 
18 h as monitored by TLC. The solvent was removed and the residue was purified 
by silica gel column chromatography (Pet Ether: Et2O = 10/1, Rf: 0.28) to afford 
46.9 mg (92 % yield) of a red solid. High-resolution mass spectroscopy (ESI): 
(M+H)
 +
: for C15H14N2O2, 255.1055. m.p : 89 
o
C (Lit m.p : 88.13 
o
C) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.28 (t, J= 7.8 Hz, 2H), 7.21 
(d, J= 6.8 Hz, 2H), 6.99-6.95 (m, 4H), 4.79 (t, J= 8.0 Hz, 1H), 4.33 (d, J= 8.0 Hz, 
2H), 3.40 (s, 3H). 
13
C-NMR (400 MHz, CDCl3): δ = 33.2(1), 43.3 (2), 79.1(3), 
99.0(4), 112.7(5), 121.5(6), 128.4(7), 128.6(8), 142.6(9).  
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4.5 Synthesis of N, N-Diallyl-3-phenyl-acrylamide (3c)
 43 
NH
CH2
CH2
N
O
CH2
CH2
Et3N
Cinnamoyl Choride 
Argon atm
DCM (dry)
0 oC
 
 
To a stirred solution of diallylamine (972 mg, 10mmol) in anhydrous DCM (15 
mL) was added NEt3 (2.79 mL, 20 mmol). The reaction mixture was cooled to O 
oC and cinnamoyl chloride (3.5g, 21 mmol) dissolved in 20 ml anhydrous DCM 
was added slowly. The cooling bath was removed and the reaction mixture was 
maintained under magnetic stirring overnight. After this period, the reaction 
mixture was quenched with water (30ml) and extracted with DCM (3x30ml). 
Combine the organic fractions and wash with brine. Dry with MgSO4, filter and 
then concentrate. Yellow oil, Purified by silica column chromatography (9:1 
DCM:MeOH Rf: 0.32) in an isolated yield of 67%. 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.72 (d, 15.25Hz, 1H, A), 
7.47-7.50(m, 2H, B), 7.31-7.37 (m, 3H, C), 6.77 (d, 15.25Hz, 1H, D), 5.76-5.90 
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(m,  2H, E), 5.13-5.26 (m, 4H, F), 4.00-4.11(m, 4H G). 
13
C-NMR (400 MHz, 
CDCl3): δ = 48.82(1), 49.32(2), 116.89(3), 117.52(4), 117.66(5), 127.9(6), 
128.86(7), 129.7(8), 133.28(9), 133.33(10), 135.37(11), 143.05(12), 166.7(13). 
 
4.6 Synthesis of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone (2a)
 44 
N
O
CH2
CH2
N
O
Grubb's 2nd gen
Argon
Toluene (dry)
Reflux 6 hr
N
N
Ru
4-
Cl
Cl PCy 3
Ph
CH3
CH3
CH3
CH3
CH3
CH3
 
 
A mixture containing N,N-diallyl-3-phenyl-acrylamide (400mg 1.2mmol) and 2
nd
 
generation Grubb’s catalyst (108mg, 0.12mmol) in anhydrous toluene was 
refluxed for 6hr under argon atmosphere. The mixture was concentrated to yield 
the crude product which was purified by column chromatography (6:4 
EtOAc/Hex, Rf: 0.4). The crude is a dark black gel that eventually solidifies. 
After column chromatography it was isolated as a white compound (0.245mg, 
61% yield).  
 
The compound should be stored in the fridge, under inert conditions (as it 
degrades over time giving an orange/yellow colour). The reaction was initially 
performed in dry DCM rather than toluene; this gave a smaller yield 22% on the 
same time scale. The reaction can also be performed at room temperature in 
toluene, though in takes considerably longer to achieve comparable yields. 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.71 (d, 1H, J= 15 Hz, A), 
7.47-49 (m, 2H, B), 7.32 (m, 3H, C), 6.72(d, 1H, 15Hz, D), 5.89(m, 2H, E), 
4.44(m, 4H, F)
13
C-NMR (400 MHz, CDCl3): δ = 52.0(1), 121.7(2), 121.9(3), 
125.1 (4), 126.8(5), 127.3(6), 136.2(7), 138.2(8), 177.3(9). 
 
4.7 Failed Cyclisation Attempt of (2a) Using Ishii System 
 
N
O
NHPI
Co(OAc)2
O2, 
Solvent
 
 
A solution of 1-(2, 5-dihydro-pyrrol-1-yl)-3-phenyl-propenone (100mg, 
0.50mmol) and NHPI (25mg, 0.15mmol) and Co (OAc) 2 (3mg, 0.0015mmol) was 
placed in a two necked flask purged with oxygen and equipped with a balloon 
filled with oxygen. The reaction was run at room temperature in 10ml DCM first, 
there was no observable reaction. The solvent was changed to acetonitrile and run 
at 80
o
C, still to no avail. The solvent was changed again to acetic acid and 
temperature increased to 100
 o
C. There was an observed reaction but a very 
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complex mixture produced. Attempts to separate and analyse components were 
unsuccessful. Control reaction was performed to ascertain the stability of the 
starting material, it was concluded that the compound was stable in acetic acid at 
100
 o
C.  
 
4.8 Synthesis of 2-chloromethyl-benzoyl chloride (5c)
47a 
 
O
O
Cl
Cl
OSOCl2
 C6H5CH2N(Cl)(C2H5)3 
Xylene
reflux
 
 
To a 1-L three-necked flask, a solution of xylene (64.3 ml), phthalide (13.41 g 100 
mmol), benzyltriethylammonium chloride (1.82 g, 8 mmol), and BF3- diethyl 
etherate (0.99 g, 14.6 mmol) were added, and heated to 100°C. Subsequently, 
thionyl chloride (14.28 g, 1.2 mmol) was added dropwise over 1 h, and stirred at 
130°C for 9 h. Xylene and excessive thionyl chloride were distilled off at normal 
pressure until the internal temperature became 135°C, and xylene was further 
distilled off under reduced pressure (160°C). Compound should be a thick light 
green free flowing liquid. The product was taken up in chloroform and left under 
vacuum several times to remove any residual thionyl chloride, leaving a clear 
liquid in 90% yield (17g, 90 mmol ). 
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Cl
Cl
OH
A
H
B
H
B
H
C
H
D
H
D
 
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 8.27 (d, J= 7.32Hz, 1H, A), 
7.59-7.72 (m, 2H, B), 7.50-7.56 (m, 1H, C), 4.90 (s, 2H, D). 
 
4.9 Synthesis of 2,3-Dihydro-isoindol-1-one (5b)
 47b
     
 
Cl
Cl
O
NH
O
NH3 (aq) 38%
EtOH
reflux
 
 
A solution of 2-(chloromethyl) benzoyl chloride (0.94g, 5.00mmol) in ethanol 
(20mL) was heated under reflux for 1 h forming a subtle pink solution. 38% 
aqueous ammonia (20mL) was added once the reaction had cooled to room 
temperature and the reflux was continued for an additional 1 h (the solution 
should turn a light orange colour initially then a light yellow when the reaction is 
complete. After the reaction has finished the reaction mixture was extracted with 
dichloromethane (3 × 30 ml). The combined extracts were dried with anhydrous 
Na2SO4, the solvent was evaporated in vacuo and the residue was recrystallized 
from benzene (or alternatively toluene), to give fine clear needle crystals of iso-
indolinone in 38% (0.25 g); Mp 151 
°
C 
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2
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1
N
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O
H
C 
H
B
H
C
H
A
H
E
H
E
H
D  
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.89 (d, 1H, J= 8.34 Hz, A), 
7.61-7.57(m, 1H, B), 7.52-7.49(m, 2H, C), 7.17(brs, 1H, D), 4.48(s, 2H, E).
13
C-
NMR (400 MHz, CDCl3): δ = 171.9(7), 143.7(6), 131.9(5), 128.1(4), 123.9(3.), 
123.3(2), 45.7(1) 
 
4.10 Synthesis of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a)
 53 
 
NH
O
N
O
CH2
Cs2CO3
BrCH2CH2CH=CH2
MeCN
reflux
 
 
To isoindolinone (250mg, 1.85mmol) in acetonitrile (10ml) was added caesium 
carbonate (2.4g, 7.39mmol) and the mixture was heated to 80
o
C. Then 4-bromo-1-
ene (518mg, 2.77mmol) in 5ml EtOAc was slowly injected into the reaction 
mixture over a period of 20 minutes. The reaction was refluxed for 3hr at 80
o
C. 
The reaction mixture was partitioned between ethyl acetate and water and the 
organic layer washed with brine and dried over anhydrous MgSO4. The solvent 
was removed under reduced pressure and the product was purified by column 
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chromatography (40%EtOAc/Pet40-60) to afford product as a yellow oil in 79% 
yield (278mg).  
  
710
8
9 5
6
3N
12
O
2
1
11
4
H
C
H
B
H
C
H
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H
F
H
F
H
G
H
G
H
H
H
HH
D
H
E
H
E
 
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.81 (d, J= 8.34 Hz, 1H, A), 
7.52-7.47 (m, 1H, B), 7.40-7.44 (m, 2H. C), 5.75-5.87 (m, 1H, D), 5.00-5.11 (m, 
2H, E), 4.37 (s, 2H, F), 3.66-3.70 (m, 2H, G), 2.39-2.45 (m, 2H. H). 
13
C-NMR 
(400 MHz, CDCl3): δ = 168.6(12), 141.2 (11), 135.1 (10), 133.0 (9), 131.3 (8), 
128.0 (7), 124.0 (6), 122.7 (5), 117.2 (4), 50.2 (3), 42.0 (2), 33.0 (1). 
 
4.11 NBS Cyclisation of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
 
N
O
CH2
N
O
Br
N
O
O
Br
Br
N
O
O
OH
Br
N
O
CH2
O
+ + +
NBS
AIBN
EtOAc
80 °C
 
 
To a solution of 2-but-3-enyl-2, 3-dihydro-indol-1-one (200mg, 1.07mmol) and 
AIBN (0.018mg, 0.107mmol) in 10 ml EtOAc. NBS (189mg, 1.07mmol) was 
added and the reaction was refluxed for 2hr. A second equivalent of NBS was 
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added along with another 0.1 equivalent of AIBN. The reflux was continued for 
another 2h. The reaction was monitored by TLC. If there was any starting material 
left, another 0.1 equivalent of AIBN was added repeatedly every hour until the 
reaction reaches completion. The solution should be a very dark orange colour. 
There should be four UV active spots visible. The reaction mixture was cooled in 
a water ice bath and filtered. The filtrate was concentrated on a rotary evaporator. 
The crude mixture is oil, orange in colour, which was then purified by column 
chromatography (4:6 EtOAc: Pet Ether 40:60). Compound A is a light yellow 
solid isolated in 6% yield; Compound B is sticky oil (orange) isolated in 31% 
yield, Compound C is a yellow crystalline solid isolated in  36% yield and 
Compound D is a white solid isolated in 27% yield. 
 
(2R*,10bS*)-2-Bromo-1,3,4,10b-tetrahydropyrido[2, 1-a]isoindol-6(2H)-one 
(11a)  
 
6
11
9
10
8
7
5
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12
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H
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H
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G H
H
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.88 (d, 1H, J= 7.32 Hz, A), 
7.55 (t, 1H, J= 7.32 Hz, B), 7.49 (t, 1H, J= 7.32 Hz, C), 7.43(d, 1H, 7.32 Hz, D), 
4.84 (dd, 1H, J= 11,3 Hz, E), 4.80, br s, 1H, F), 4.46 (dd, 1H, J= 14, 5, G), 3.49 
(td, 1H, J= 15, 3 Hz, H), 2.69 (d, 1H, J= 13 Hz, I), 2.17 (d, 1H, J= 14 Hz, J), 1.91 
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(m, 1H, K), 1.61 (ddd, 1H, J= 3, 11, 14 Hz, L). 
13
C-NMR (400 MHz, CDCl3): δ = 
161.0(12), 145.0(11), 132.4(10), 131.5(9), 128.5(8), 124.1(7), 121.8(6), 54.1(5), 
49.3(4), 39.6(3), 34.9(2), 33.4(1).  
 
2-(4-Bromo-3-hydroxybutyl)-1H-isoindole-1,3(2H)-dione (11d) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.82-7.97 (dd, 2H, J= 3, 8.59 
Hz, A), 7.70-7.75 (dd, 2H, J= 3 Hz, 8.54, B), 3.85-3.91 (dd, J= 3, 7.63 Hz, 2H), 
3.80(m,1H), 3.46-3.51(m,1H), 3.39-3.44(m,1H), 3.09(m, 1H), 1.91-2.00(m,1H), 
1.80-1.89(m,1H). 
13
C-NMR (400 MHz, CDCl3): δ = 168.8(8), 134.3(7), 132.0(6), 
123.4(5), 68.5(4), 38.9(3), 34.7(2), 34.2(1). 
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Compound C: 2-(3,4-Dibromobutyl)-1H-isoindole-1,3(2H)-dione (11c) 
5
7
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H
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H
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G
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F
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E H
C
H
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.85-7.88 (m, 2H, A), 7.72-
7.74 (m, 2H, B), 4.14-4.21(1H), 3.84-3.99(m, 3H, D), 3.64-3.70(m, 1H, E), 2.53-
2.67(m, 1H, F), 2.13-2.23(m, 1H, G). 
13
C-NMR (400 MHz, CDCl3): δ = 168.2(8), 
134.2(7), 123.3(6), 121.4(5), 48.8(4), 36.0(3), 35.8(2), 34.9(1). 
 
4.12 NIS Cyclisation of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
 
N
O
CH2
N
O
I N
O
O
I
I
N
O
O
OH
I
N
O
CH2
OH
+ + +
NIS
AIBN
EtOAc
80 °C
 
          
To a solution of 2-but-3-enyl-2, 3-dihydro-indol-1-one (200mg, 1.07mmol) and 
AIBN (0.018mg, 0.107mmol) in 10ml EtOAc, NIS (189mg, 1.07mmol) was added 
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and the reaction was refluxed for 2h. A second equivalent of NIS was added along 
with another 0.1 equivalent of AIBN. The reflux was continued for another 2hrs. 
The reaction was monitored by TLC. If there was any starting material left, 
another 0.1 equivalent of AIBN was added repeatedly every hour until the 
reaction reaches completion. The solution should be a dark pink almost maroon 
colour. There should be four UV active spots visible. The reaction mixture was 
cooled in a water ice bath and filtered. The filtrate was concentrated on a rotary 
evaporator. The crude mixture is oil, black/red in colour, which was then purified 
by column chromatography (6:4 EtOAc: Pet Ether 40:60). Compound 1 is 
diastereomeric mixture, a light pink solid isolated in 8% yield (Rf: 0.35); 
Compound 2 is sticky oil isolated in 39% yield (Rf: 0.46), Compound 3 is a pink 
solid isolated in 24% yield (Rf: 0.53) and Compound 4 is a white solid isolated in 
29% yield (Rf: 0.67).  
 
 (1): (2S*,10bS*)-2-Iodo-1,3,4,10b-tetrahydropyrido[2,1-a]isoindol-6(2H)-one 
(13a) 
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*1: NMR Assignment: 
1
H-NMR (700 MHz, CDCl3) δ:   7.86(d, 1H, J= 7 Hz, A), 
7.54(t, 1H, J= 7 Hz, B), 7.47-48(t, 1H, J= 7 Hz, C), 7.40(d, 1H, J= 8 Hz, D), 
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4.90(br s, 1H, E), 4.78(dd, 1H, J= 11, 3 Hz, F), 4.46(dd, 1H, J= 14, 4 Hz, G), 
3.38(td, 1H, J= 15, 3 Hz, H), 2.64(d, 1H, J= 13 Hz, I), 2.12(d, 1H, 15 Hz, J), 1.56-
1.68(m, 1H, K), 1.35(ddd, J= 14, 12, 3 Hz, L). 
13
C-NMR (400 MHz, CDCl3): δ = 
166.0(12), 144.8(11), 132.4(10), 131.5(9), 128.5(8), 124.1(7), 121.9(6), 55.9(5), 
41.0(4), 36.7(3), 34.7(2), 29.2(1).  
 
Compound E (2): (2R*,10bS*)-2-Iodo-1,3,4,10b-tetrahydropyrido[2,1-
a]isoindol-6(2H)-one (13a) 
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*2: NMR Assignment: 
1
H-NMR (700 MHz, CDCl3) δ: 7.86(d, 1H, J= 7 Hz, A), 
7.54(t, 1H, J= 7 Hz, B), 7.47-48(t, 1H, J= 7 Hz, C), 7.40(d, 1H, J= 8 Hz, D), 4.30-
4.40(m, 2H, E), .30-4.40(m, 1H, E*), 3.00-3.07 (m, 1H, F), 3.00-3.07 (m, 1H, F*),  
2.49(br d, J=12 Hz, 1H, G), 2.00-2.08(m, 1H, H), 1.80(q, 1H, J= 12 Hz, I). 
13
C-
NMR (400 MHz, CDCl3): δ = 166.3(12), 143.8(11), 132.0(10), 131.7(9), 128.7(8), 
124.0(7), 121.8(6), 60.0(5), 44.8(4), 40.1(3), 38.7(2), 20.0(1).  
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Compound G: 2-(3-Hydroxy-4-iodobutyl)-1H-isoindole-1,3(2H)-dione (13d) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.85 (m, 2H, A), 7.72 (m, 2H, 
B), 3.88(m, 2H, C), 3.56(m, 1H, D), 3.33 (m, 1H, E), 3.25(m, 1H, F), 3.05(m, 1H, 
G), 1.98 (m, 1H, H), 1.81(m, 1H, I). 
13
C-NMR (400 MHz, CDCl3): δ = 168.8(8), 
134.3(7), 132.6(6), 123.3(5), 68.4(4), 35.6(3), 34.7(2), 14.0(1). 
 
Compound H: 2-(but-3-en-1-yl)-3-hydroxy-2,3-dihydro-1H-isoindol-1-one 
(13b) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3) δ: 7.63 (m, 1H), 7.60(m, 1H), 
7.57(m, 1H), 7.46(m, 1H), 5.78-5.85(m, 1H), 5.73-5.78(m, 1H), 4.99-5.1(m, 1H), 
3.55-3.63(m, 1H), 3.35-3.43(m, 1H), 3.22(m, 1H), 2.34-2.45(m, 2H). 
13
C-NMR 
(400 MHz, CDCl3): δ = 167.4, 143.4, 138.3, 132.3, 131.6, 129.9, 123.4, 117.2, 
82.0, 38.8, 32.8.  
 
4.13 Synthesis 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one (4a)
48 
 
NH
O
N
O
O
NaH (1.25 equiv)
C6H5CH=CHCOCl
DCM
0 oC
 
 
Sodium hydride (1.54g, 1.25 equiv) was placed under N2 in an oven dried round 
bottom flask (500ml).  Sodium hydride was washed with hexane. Anhydrous 
DCM (100ml) was added to the sodium hydride. To this grey suspension was 
added a solution of isoindolinone (5.47g, 0.041mol) in dry DCM (50ml). In a 
separate oven dried 500ml round bottom flask, cinamoyl chloride (2.5 
equivalents) and dry DCM (100ml) were placed.  
 
The flask containing the iso-indolinone/sodium hydride solution was cooled in a 
water/ice bath, and the cinnamoyl chloride solution was slowly injected into the 
flask slowly over a period of 30 minutes.  The reaction was left to stir for 24 
hours.  The reaction was quenched with water and extracted with DCM, dry 
organic layers were dried with MgSO4, filtered and concentrated. White solid was 
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obtained and re-crystallise from benzene; to obtain thin white fluffy needles in 
66% yield. 
 
2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one (4a) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 8.26 (d, 1H, J= 15.9 Hz), 
7.93-7.97 (m, 2H), 7.67-7.71 (m, 3H), 7.52-7.56 (m, 2H), 7.40-7.43 (m, 3H), 4.95 
(s, 2H).
13
C-NMR (400 MHz, CDCl3): δ = 168.0, 166.4, 146.1, 141.4, 135.0, 
134.3, 131.6, 130.6, 128.9, 128.8, 125.4, 123.6, 119.2, 48.7. 
 
4.14 Synthesis of 3-hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-dihydro-1H-
isoindol-1-one (9b) 
 
N
O
O
N
O
O
OH
NBS
AIBN
EtOAc
80 °C
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To a solution of 2-(3-phenyl-acryloyl)-2,2-dihydro-isoindol-1-one (350mg, 
1.35mmol) and AIBN (0.00215g, 0.0135mmol) in 20ml EtOAc,  NBS (235mg, 
1.35mmol) was added and the reaction was refluxed for 12hr. The reaction 
mixture was cooled and filtered then concentrated. The crude (a light brown solid 
which rapidly turns black when left in sample vial) was purified by column 
chromatography (EtOAc: Hex 1:1), to afford a white solid (262mg, Rf: 0.43). 
 
3-Hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-dihydro-1H-isoindol-1-one (9b) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 8.16 (d, 1H, J= 15.7 Hz, A), 
7.99 (d, 1H, 15.7 Hz, B), 7.94 (d, 1H, 7.7Hz, C), 7.76 (m, 1H, D), 7.70 (m, 3H, 
E), 7.63 (m, 2H, F), 7.44 (m, 2H, G), 6.69 (d, 1H. H), 4.74 (d, 1H, I). 
13
C-NMR 
(400 MHz, CDCl3): δ = 81.3(1), 118.7(2), 124.2(3), 125.1(4), 128.8(5), 129.0(6), 
130.7(7), 130.9(8), 134.7(9), 134.8(10), 142.3(11), 146.9(12), 166.4(13), 
167.6(14). 
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4.15 Failed Cyclisation Attempt of 4a Using Ishii System 
 
N
O
O
NHPI
Co(OAc)2
O2, RT
Solvent
 
 
A solution of 2-(3-Phenyl-acryloyl)-2, 2-dihydro-isoindol-1-one (100mg), NHPI 
(25mg, 0.15mmol) and Co (OAc) 2 (3mg, 0.0015mmol) were placed in a two 
necked flask purged with oxygen equipped with a balloon filled with oxygen. The 
reaction was run at room temperature in 10ml DCM first, there was no observable 
reaction. The solvent was changed to acetonitrile and run at 80
o
C; still no 
reaction. The solvent was changed again to acetic acid and temperature increased 
to 110
 o
C. There was no observed reaction.  
 
4.16 Failed Cyclisation Attempt of 4a Using Triethylborane as Initiator 
 
N
O
O
Et3B/O2
THF, 0 °C
 
 
89 
 
2-(3-Phenyl-acryloyl)-2, 2-dihydro-isoindol-1-one (100mg, 0.38mmol) was 
dissolved in THF (10mL), purged with oxygen and sealed affixing a balloon filled 
with O2 to the sealed vessel. Solution was cooled in a water/ice bath to 0
o
C at 
which point 1 equivalent of triethylborane dissolved in THF was injected into the 
reaction flask very slowly using an autosyringe over 1 h. No reaction was 
observed. Injection of two equivalents of Et3B also did not result in an observable 
reaction. The reaction was also performed at room temperature, no reaction was 
observed.  
 
4.17 Failed TEMPO Catalysed Coupling Reaction of 4a to Nitromethane 
 
N
O
O
TEMPO 10%
Nitromethane
O2, 60 
oC
AcOH
 
 
2-(3-Phenyl-acryloyl)-2, 2-dihydro-isoindol-1-one (52.0mg, 0.2mmol) and 
TEMPO (3.2 mg, 0.02 mmol) were placed in a 25 ml round bottom flask. Then 
CH3NO2 (0.5 mL) was added. The reaction mixture was stirred at 60 °C under O2 
(1 atm) for 24 h, no reaction was observed. 
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4.18 Synthesis of 2-Benzyl-2,3-dihydro-isoindol-1-one (14a)
53 
 
NH
O
N
O
Cs2CO3
BrCH2C6H5
reflux
 
 
To isoindolinone (250mg, 1.85mmol) in acetonitrile (10ml) was added caesium 
carbonate (2.4g, 7.39mmol) and the mixture was heated to 80
o
C. Then benzyl 
bromide (2.77mmol) in 5ml EtOAc was slowly injected into the reaction mixture 
over a period of 20 minutes. The reaction was refluxed for 3hr at 80
o
C. The 
reaction mixture was partitioned between ethyl acetate and water and the organic 
layer washed with brine and dried over anhydrous MgSO4. The solvent was 
removed under reduced pressure and the product was purified by column 
chromatography (40%EtOAc/Pet40-60) to afford a white solid in 80% yield (Rf 
0.26). High-resolution mass spectroscopy (ESI): (M+H)
 +
: for C15H13NO, 224.09; 
m.p: 139.4 
o
C 
 
2-Benzyl-2,3-dihydro-isoindol-1-one (14a) 
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NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.90 (d, 1H, A), 7.50-7.55 
(m, 1H, B), 7.45-7.50 (m, 1H, C), 7.37-7.40 (d, 1H, D), 7.31-7.33 (m, 3H, E), 
7.28-7.31 (m, 1H, F), 4.81 (s, 2H, G), 4.27 (s, 2H, H). 
13
C-NMR (400 MHz, 
CDCl3): δ = 168.0(12), 141.3(11), 137.1(10), 132.7(9), 128.9(8), 128.3(7), 
128.1(6), 127.8(5), 124.0(4), 122.8(3), 49.5(2), 48.5(1). 
 
4.19 Synthesis of 2-Phenyl-2,3-dihydro-isoindol-1-one (15a)
 47b
 
 
N
O
Cl
Cl
O
Et3N (1 equiv)
DBU (1 equiv)
C6H5NH2
DCM
RT, 4 hr
 
 
To a stirred solution of aniline (5.50 mmol) and triethylamine (5.50mmol) in dry 
dichloromethane (30ml) the solution of benzoyldichloride (5.00mmol) in dry 
dichloromethane (20ml) was added dropwise at room temperature for 30 min. 
After additional 2 hr DBU (10.10mmol) was added. The reaction was continued 
for additional 2hr at room temperature. After the reaction was finished, 
dichloromethane was evaporated in vacuo and the residue was separated by silica 
gel chromatography (40%EtOAc/Pet40-60). An off white powder was isolated in 
63% yield (Rf: 0.3) 
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2-Phenyl-2,3-dihydro-isoindol-1-one (15a) 
 
6
11
8
9
4
5
1
N
12
O
10
2 7
3
H
B
H
C
H
B
H
A
H
G
H
G
H
D
H
D
H
E
H
E
H
F  
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.94 (d, 1H), 7.85, (d, 2H), 
7.58-7.63 (m, 1H), 7.49-7.54 (m, 2H), 7.41-7.45 (m, 2H), 7.16-7.21 (m, 1H), 4.87 
(s, 2H).
13
C-NMR (400 MHz, CDCl3): δ = 167.6(12), 140.20(11), 139.6(10), 
133.33(9), 132.2(8), 129.3(7), 128.6(6), 124.6(5), 124.2(4), 122.7(3), 119.5(2), 
50.8(1). 
 
4.20 Synthesis of 2-methyl-2,3-dihydro-isoindol-1-one (16a)
53 
 
NH
O
N
O
CH3
Cs2CO3
MeI
MeCN
reflux
 
 
To isoindolinone (250 mg, 1.85 mmol) in acetonitrile (10 ml) was added 
iodomethane (393 mg, 2.77 mmol) and caesium carbonate(2.4 g, 7.39 mmol) and 
the mixture was allowed to stir at 80 
o
C for 3 h. The reaction mixture was 
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partitioned between ethyl acetate and water and the organic layer washed with 
brine and dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure and the product was purified by column chromatography 
(40%EtOAc/Pet40-60) to afford the product as a white solid (190 mg Rf: 0.38). 
High-resolution mass spectroscopy (ESI): (M+H)
 +
: for C9H9NO, 148.06; m.p: 
76.2 
o
C 
 
Methyl-2,3-dihydro-isoindol-1-one (16a) 
5
8
6
7
3
4
2
N
9
O 1
H
C
H
B
H
C
H
A
H
D
H
D
H
E H
E
H
E
 
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.82 (d, 1H, A), 7.48-7.53 
(m, 1H, B), 7.40-7.45 (m, 2H, C), 4.35 (s, 2H, D), 3.18 (s, 3H, E). 
13
C-NMR (400 
MHz, CDCl3): δ = 168.6(9), 144.1(8), 133.0(7), 131.2(6), 128.0(5), 123.6(4), 
122.7(3), 52.1(2), 29.5(1). 
 
4.21 Synthesis of 2-Allyl-2,3-dihydro-isoindol-1-one (17a)
53 
 
NH
O
N
O
CH2
Cs2CO3
Br~CH2CH=CH2
MeCN
reflux
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To isoindolinone (250mg, 1.85mmol) in acetonitrile (10ml) was added caesium 
carbonate (2.4g, 7.39mmol) and the mixture was heated to 80
o
C. Then allyl 
bromide (518mg, 2.77mmol) in 8ml EtOAc was slowly injected into the reaction 
mixture over a period of 20 minutes. The reaction was refluxed for 5h at 80
o
C. 
The reaction mixture was partitioned between ethyl acetate and water and the 
organic layer was washed with brine and dried over anhydrous MgSO4. The 
solvent was removed under reduced pressure and the product was purified by 
column chromatography (40%EtOAc/Pet40-60) to afford the title product as 
yellow oil in 79% yield (278mg, Rf: 0.27).  High-resolution mass spectroscopy 
(ESI): (M+H)
 +
: for C11H11NO, 174.08; m.p: 94.5 
o
C  
 
2-Allyl-2,3-dihydro-isoindol-1-one (17a) 
6
10
7
8
4
5
1
N
11
O 2
9
3
H
C
H
B
H
C
H
A
H
F
H
F
H
G
H
G
H
D
H
E
H
E
 
 
NMR Assignment: 
1
H-NMR (400 MHz, CDCl3): δ = 7.73 (m, 1H, A), 7.39-7.44 
(m, 1H, B), 7.31-7.36 (m, 2H, C), 5.70-5.80 (m, 1H, D), 5.10-5.16 (m, 2H, E), 
4.23 (m, 2H, F), 4.10-4.14 (m, 2H, G). 
13
C-NMR (400 MHz, CDCl3): δ = 
168.3(11), 141.3(10), 134.1(9), 133.0(8), 131.3(7), 128.0(6), 123.6(5), 122.8(4), 
117.9(3), 49.6(2), 45.0(1). 
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Appendices 
 
1. Abbreviations 
 
AcOH: Acetic Acid 
AZADO: Azanoradamantane N-oxyl 
AIBN: Azobisisobutyronitrile 
BDE: Bond dissociation energy 
BuLi: Butyllithium 
PhCl: Chlorobenzene 
COSY: Correlation spectroscopy 
DBU: 1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCM: Dichloromethane 
DEAD: Diethyl azodicarboxylate 
DMF: Dimethylformamide 
ESI: Electrospray ionization 
EtOH: Ethanol 
EtOAc: Ethyl Acetate 
5-F-AZADO: 5-Fluro-2-azaadamantane N-oxyl 
HMBC: Heteronuclear Multiple-bond Correlation spectroscopy 
HSQC: Heteronuclear Single Quantum Coherence spectroscopy 
MEHQ: Hydroquinone Monomethyl Ether 
Hex: Hexane 
LUMO: Lowest unoccupied molecular orbital 
MeI: Methyl iodide 
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NHPI: N-hydroxyphthalimide 
NBS: N-Bromosuccinimide 
NCS: N-Chlorosuccinimide 
NIS: N-Iodosuccinimide 
NMR: Nuclear magnetic resonance 
NOESY: Nuclear Overhauser effect spectroscopy 
PINO: Phthalimide-N-oxyl 
t-BuOK: Potassium tert-butoxide 
nBu3SnH: Tributyltin hydride 
Ph3SnH: Triphenyltin hydride 
Rf: Retardation factor 
RSA: Retrosynthetic Analysis 
RT: Room temperature 
SOMO: Singly Occupied Molecular Orbital 
THF: Tetrahydrofuran 
TLC: Thin layer chromatography 
Et3N: Triethylamine 
Et3B: Triethylborane 
TFA: Trifluoroacetic acid 
TfOH: Trifluoromethanesulfonic acid 
TOCSY: Total correlation spectroscopy 
UV: Ultraviolet 
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2. Tabulated results for diastereomer 2 (13a) 
 
Proto
n 
δ(pp
m) 
App
, 
Int
. 
J(Hz
) 
COSY HSQ
C 
HMBC  
A 7.85 d 1 7 HC C7 C9.C11. C12 
B 7.54 t 1 7 HD C9 - 
C 7.47 t 1 7 HA C8 C6,C10 
D 7.41 d 1  HB C6 C8,C9, C5(w) 
E 7.30-
40 
m 2  HF,HH,HG(w),
HI 
C1, 
C3 
C1.C2,C4(w),C5,C12
(w) 
E*   1  HI, HF C5 C4,C11,C12() 
F 3.00-
07 
m 1  HE/E*,HG(w), 
HH(w) 
C3 C1,C2,C12 
F*   1  HI C4 C5(w) 
G 2.49 d 1  HH, HF/F*, 
HE/E* 
C2 - 
H 2.00-
08 
m 1  HG, HF/F*, 
HE/E* 
C2 C1, C3, C4(w), 
C12(w) 
I 1.80 q 1 12 HF/F*, HE/E* C4 C1.C2(w),C5,C11 
 
Table 4: Tabulated results for diastereomer 2, (13a) (700MHz, CDCl3) 
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Carbon δ(ppm) HSQC 
1 20.0 HE 
2 38.7 HG,HH 
3 40.1 HE,HF 
4 44.8 HI,HF* 
5 60.0 HE* 
6 121.8 HD 
7 124.0 HA 
8 128.7 HC 
9 131.7 HB 
10 132.0 - 
11 143,8 - 
12 166.3 - 
 
Table 5: Tabulated results for diastereomer 2, (13a) (700MHz, CDCl3) 
 
3. List of NMR spectra  
 
1. 1H NMR spectrum of 2,3-Dihydro-isoindol-1-one (5b) (400 MHz) (Figure 
72)        
2. 13C NMR spectrum of 2,3-Dihydro-isoindol-1-one (5b) (400 MHz) 
(Figure 73)      
3. 1H NMR spectrum of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one 
(4a) (400 MHz) (Figure 74) 
4.  13C NMR spectrum of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one 
(4a) (400 MHz) (Figure 75) 
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5. 1H NMR spectrum of 3-hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-
dihydro-1H-isoindol-1-one (9b) (Figure 76) 
6. 13C NMR spectrum of 3-hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-
dihydro-1H-isoindol-1-one (9b) (Figure 77) 
7. 1H NMR spectrum of 2-Allyl-2,3-dihydro-isoindol-1-one (17a) (Figure 
78) 
8. 13C NMR spectrum of 2-Allyl-2,3-dihydro-isoindol-1-one (17a) (Figure 
79) 
9.  1H NMR spectrum of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
(Figure 80) 
10.  13C NMR spectrum of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
(Figure 81) 
11. 1H NMR spectrum of (2R, 10bS)-2-bromo-1,3,4,10b-tetrahydropyrido [2, 
1-a] isoindol-6(2H)-one (11a)  (Figure 82) 
12. 13C NMR spectrum of (2R, 10bS)-2-bromo-1,3,4,10b-tetrahydropyrido [2, 
1-a] isoindol-6(2H)-one (11a) (Figure 83) 
13.  1H NMR spectrum of (2S & 2R, 10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2, 1-a] isoindol-6(2H)-one (13a) (Figure 84) 
14. 13C NMR spectrum of (2S & 2R, 10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2, 1-a] isoindol-6(2H)-one (13a) (Figure 85) 
15. 1H NMR spectrum of 2-Methyl-2,3-dihydro-isoindol-1-one (16a) (Figure 
86) 
16. 13C NMR spectrum of 2-Methyl-2,3-dihydro-isoindol-1-one (16a) (Figure 
87) 
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17. 1H NMR spectrum of 2-Phenyl-2,3-dihydro-isoindol-1-one (15a) (Figure 
88) 
18. 13C NMR spectrum of 2-Phenyl-2,3-dihydro-isoindol-1-one (15a) (Figure 
89) 
19. 1H NMR spectrum of 2-Benzyl-2,3-dihydro-isoindol-1-one (14a) (Figure 
90) 
20. 13C NMR spectrum of 2-Benzyl-2,3-dihydro-isoindol-1-one (14a) (Figure 
91) 
21. 1H NMR spectrum of N,N-Diallyl-3-phenyl-acrylamide (3c) (Figure 92) 
22. 13C NMR spectrum of N,N-Diallyl-3-phenyl-acrylamide (3c) (Figure 93) 
23.  1H NMR spectrum of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone 
(2a) (Figure 94) 
24.  13C NMR spectrum of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone 
(2a) (Figure 95) 
25. 1H NMR spectrum of 9,10-Dihydro-acridine (3b) (Figure 96) 
26. 13C NMR spectrum of 9,10-Dihydro-acridine (3b) (Figure 97) 
27. 1H NMR spectrum of 10-Methyl-9,10-dihydro-acridine (3c) (Figure 98) 
28.  13C NMR spectrum of 10-Methyl-9,10-dihydro-acridine (3c) (Figure 99) 
29. 1H NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine (3d) 
(Figure 100) 
30. 13C NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine 
(3d) (Figure 101) 
31. 1H NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1,3(2H)-dione 
(11c) (Figure 102) 
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32. 13C NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1,3(2H)-dione 
(11c) (Figure 103) 
33. 1H NMR spectrum of 2-(3-hydroxy-4-iodobutyl)-1H-isoindole-1,3(2H)-
dione (13d) (Figure 104) 
34.  1H NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1,3(2H)-
dione (11d) (Figure 105) 
35. 13C NMR spectrum of 2-(3-hydroxy-4-iodobutyl)-1H-isoindole-1,3(2H)-
dione (13d) (Figure 106) 
36. 13C NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1, 
3(2H)-dione (11d) (Figure 107) 
37. 1H NMR spectrum of 2-(but-3-en-1-yl)-3-hydroxy-2,3-dihydro-1H-
isoindol-1-one (13b) (Figure 108) 
38. 13C NMR spectrum of 2-(but-3-en-1-yl)-3-hydroxy-2,3-dihydro-1H-
isoindol-1-one (13b) (Figure 109) 
39. 1H NMR spectrum of (2S & 2R, 10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2,1-a] isoindol-6(2H)-one (13a) (700 MHz) (Figure 110) 
40. 13C NMR spectrum of (2S & 2R, 10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2,1-a] isoindol-6(2H)-one (13a) (700 MHz) (Figure 111) 
41. TOCSY NMR spectrum (2S & 2R,10bS)-2-iodo-1,3,4,10b-
tetrahydropyrido [2,1-a] isoindol-6(2H)-one (13a) (700 MHz) (Figure 
112) 
42. HMBC NMR spectrum (2S & 2R, 10bS)-2-iodo-1,3,4,10b-
tetrahydropyrido [2, 1-a] isoindol-6(2H)-one (13a) (700 MHz) (Figure 
113) 
102 
 
43. COSY NMR diastereomer 1 magnified spectrum protons E-G (13a) (700 
MHz) (Figure 114) 
44. COSY NMR diastereomer 1 magnified spectrum protons H-I (13a) (700 
MHz) (Figure 115) 
45.  COSY NMR diastereomer 1 magnified spectrum protons J-L (13a) (700 
MHz) (Figure 116) 
46. 1H NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine (8d) 
(Figure 117) 
47. 13C NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine 
(8d) (Figure 118) 
48.  COSY NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1, 3(2H)-
dione (11c) (Figure 119) 
49. COSY NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1, 
3(2H)-dione (11d) (Figure 120) 
50. HSQC NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1, 
3(2H)-dione (11d) (Figure 121) 
51. COSY NMR spectrum of (2R, 10bS)-2-bromo-1,3,4,10b-tetrahydropyrido 
[2,1-a] isoindol-6(2H)-one (11a) (Figure 122) 
52. 1H NMR spectrum of  Methyl-2-hydroxy-3-(2-methyl-1,3-dioxolan-2-yl) 
propanoate (1c) (Figure 123) 
53.  1H NMR spectrum of  Ethylene glycol monoacetate (1f) (Figure 124) 
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                     Figure 72: 
1
H NMR spectrum of 2,3-Dihydro-isoindol-1-one (5b) (400 MHz) 
4. NMR Spectra 
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 Figure 73: 
13
C NMR spectrum of 2,3-Dihydro-isoindol-1-one (5b) (400 MHz) 
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Figure 74 
1
H NMR spectrum of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-
one (4a) (400 MHz) 
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Figure 75 
13
C NMR spectrum of 2-(3-Phenyl-acryloyl)-2,2-dihydro-isoindol-1-one 
(4a) (400 MHz) 
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 Figure 76 
1
H NMR spectrum of 3-hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-dihydro-
1H-isoindol-1-one (9b) 
108 
 
 
Figure 77 
13
C NMR spectrum of 3-hydroxy-2-[(2E)-3-phenylprop-2-enoyl]-2,3-dihydro-
1H-isoindol-1-one (9b) 
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Figure 78 
1
H NMR spectrum of 2-Allyl-2,3-dihydro-isoindol-1-one (17a) 
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 Figure 79 
13
C NMR spectrum of 2-Allyl-2,3-dihydro-isoindol-1-one (17a) 
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Figure 80 
1
H NMR spectrum of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
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Figure 81 
13
C NMR spectrum of 2-But-3-enyl-2,3-dihydro-indol-1-one (10a) 
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Figure 82 
1
H NMR spectrum of (2R, 10bS)-2-bromo-1,3,4, 10b-tetrahydropyrido [2,1-a] 
isoindol-6(2H)-one (11a)  
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Figure 83 
13
C NMR spectrum of (2R,10bS)-2-bromo-1,3,4, 10b-tetrahydropyrido [2,1-
a] isoindol-6(2H)-one (11a) 
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Figure 84 
1
H NMR spectrum of (2S & 2R,10bS)-2-iodo-1,3,4,10b-tetrahydropyrido [2,1-a] 
isoindol-6(2H)-one (13a) 
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Figure 85 
13
C NMR spectrum of (2S & 2R,10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2,1-a] isoindol-6(2H)-one (13a) 
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Figure 86 
1
H NMR spectrum of 2-Methyl-2,3-dihydro-isoindol-1-one (16a) 
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Figure 87 
13
C NMR spectrum of 2-Methyl-2,3-dihydro-isoindol-1-one (16a) 
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Figure 88 
1
H NMR spectrum of 2-Phenyl-2,3-dihydro-isoindol-1-one (15a) 
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Figure 89 
13
C NMR spectrum of 2-Phenyl-2,3-dihydro-isoindol-1-one (15a) 
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Figure 90 
1
H NMR spectrum of 2-Benzyl-2,3-dihydro-isoindol-1-one (14a) 
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Figure 91 
13
C NMR spectrum of 2-Benzyl-2,3-dihydro-isoindol-1-one (14a) 
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Figure 92 
1
H NMR spectrum of N,N-Diallyl-3-phenyl-acrylamide (3c) 
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Figure 93 
13
C NMR spectrum of N,N-Diallyl-3-phenyl-acrylamide (3c) 
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Figure 94 
1
H NMR spectrum of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone (2a) 
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Figure 95 
13
C NMR spectrum of 1-(2,5-Dihydro-pyrrol-1-yl)-3-phenyl-propenone 
(2a) 
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Figure 96 
1
H NMR spectrum of 9,10-Dihydro-acridine (3b) 
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Figure 97 
13
C NMR spectrum of 9,10-Dihydro-acridine (3b) 
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Figure 98 
1
H NMR spectrum of 10-Methyl-9,10-dihydro-acridine (3c) 
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Figure 99 
13
C NMR spectrum of 10-Methyl-9,10-dihydro-acridine (3c) 
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Figure 100 
1
H NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine (3d) 
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Figure 101 
13
C NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine 
(3d) 
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Figure 102 
1
H NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1,3(2H)-dione (11c) 
- 
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Figure 103 
13
C NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1,3(2H)-dione (11c) 
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Figure 104 
1
H NMR spectrum of 2-(3-hydroxy-4-iodobutyl)-1H-isoindole-1,3(2H)-dione (13d) 
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Figure 105 
1
H NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1,3(2H)-
dione (11d) 
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Figure 106 
13
C NMR spectrum of 2-(3-hydroxy-4-iodobutyl)-1H-isoindole-1,3(2H)-
dione (13d) 
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Figure 107 
13
C NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1,3(2H)-
dione (11d) 
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Figure 108 
1
H NMR spectrum of 2-(but-3-en-1-yl)-3-hydroxy-2,3-dihydro-1H-isoindol-1-
one (13b) 
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Figure 109 
13
C NMR spectrum of 2-(but-3-en-1-yl)-3-hydroxy-2,3-dihydro-1H-
isoindol-1-one (13b) 
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Figure 110 
1
H NMR spectrum of (2S & 2R,10bS)-2-iodo-1,3,4,10b-
tetrahydropyrido [2,1-a] isoindol-6(2H)-one (13a) (700 MHz) 
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Figure 111 
13
C NMR spectrum of (2S & 2R,10bS)-2-iodo-1,3,4,10b-tetrahydropyrido 
[2,1-a] isoindol-6(2H)-one (13a) (700 MHz) 
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Figure 112 TOCSY NMR spectrum (2S & 2R,10bS)-2-iodo-1,3,4,10b-
tetrahydropyrido [2,1-a] isoindol-6(2H)-one (13a) (700 MHz) 
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Figure 113 HMBC NMR spectrum (2S & 2R,10bS)-2-iodo-1,3,4,10b-
tetrahydropyrido [2,1-a] isoindol-6(2H)-one (13a) 
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Figure 114 COSY NMR diastereomer 1 magnified spectrum protons E-G 
(13a) (700 MHz) 
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Figure 115 COSY NMR diastereomer 1 magnified spectrum protons H-I (13a) 
(700 MHz) 
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Figure 116 COSY NMR diastereomer 1 magnified spectrum protons J-L (13a) (700 
MHz) 
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Figure 117 
1
H NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine 
(8d) 
 
149 
 
 
 
 
 
 
Figure 118 
13
C NMR spectrum of 10-Methyl-9-nitromethyl-9,10-dihydro-acridine (8d) 
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Figure 119 COSY NMR spectrum of 2-(3,4-dibromobutyl)-1H-isoindole-1,3(2H)-dione 
(11c) 
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Figure 120 COSY NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1, 
3(2H)-dione (11d) 
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Figure 121 HSQC NMR spectrum of 2-(4-bromo-3-hydroxybutyl)-1H-isoindole-1,3(2H)-dione (11d) 
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Figure 122 COSY NMR spectrum of (2R, 10bS)-2-bromo-1,3,4,10b-tetrahydropyrido [2,1-a] 
isoindol-6(2H)-one (11a) 
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Figure 123 
1
H NMR spectrum of Methyl-2-hydroxy-3-(2-methyl-1,3-dioxolan-2-
yl) propanoate (1c) 
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Figure 124 
1
H NMR spectrum of Ethylene glycol monoacetate (1f) 
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